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Abstract 
 
Recombinant DNA expression constitutes a major approach in gene function studies that naturally 
complement genetic and genomic research. Expression systems provide an invaluable tool for 
investigating the roles of novel gens, either in their original cellular environment or in specialized host 
organisms, to express high quantities of recombinant proteins for biochemical studies and structural 
determination, or even for industry applications or medical applications. Higher yield of proteins are 
achieved in prokaryotic systems and E. coli is the traditional host for producing recombinant protein. 
Its drawback of poor post-translational modifications when compared to a eukaryote organism, gave 
S.cerevisiae a chance to stand out as expression system. It’s well known genetics, influence on 
mankind’s economics and culture in beer wine and bread making during centuries, its GRAS status, fast 
and easy growth to high densities with low cost medium, along with its eukaryote machinery made it 
one of the most appreciated expression systems used today. Genetic engineering is one of the best 
tools to improve already existent strains, however yeast libraries harbour huge biodiversity with 
uncharacterized strains from witch much profit can be taken. New enzymes, new organic molecules 
and new strains with specific enhanced capacities can be lying in this libraries. 
In this project, S. cerevisiae library of wine and vineyeard strains was screened to discover and validate 
a S. cerevisiae expression strain. The screen was prepared first by assembling an expression vector 
with the pAMT20 shuttle vector as backbone, mus musculus salivary α-Amylase as reporter enzyme, 
KanMX4 as selection marker, and K. Lactis α-mating factor prepro peptide as secretion leader. 
Transformation was adapted and carried on in a high throughput manner to screen the library and 
activity seen as halos formed around colonies in agar plates supplements with starch. Two commercial 
lab strains were used as reference for protein production levels, and to do so, a large-scale expression 
in liquid medium was performed and protein purified from supernatant in various steps, and activity 
measured to set a threshold for later comparison with the yeast candidates selected from the library. 
From 400 strains, 3 candidates stood out the average and are serious candidates to proceed with 
validations as a strain to produce recombinant protein. 
 
Keywords: S.cerevisiae, High-throughput, Screening, Expression system, Yeast library, protein 
purification, α-Amylase 
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Resumo 
 
A expressão de ADN recombinante é uma abordagem abundantemente utilizada para estudar 
a função de genes complementando as áreas de investigação genética e genómica. Os sistemas de 
expressão representam ferramentas valiosas para investigar a função de novos genes, expressando-os 
em grandes quantidades, quer nos hospedeiros aos quais pertencem ou em sistemas heterólogos, para 
estudos de caracterização bioquímica, determinação de estrutura 3D, e ate para serem usados na 
indústria ou na área da medicina. Os sistemas procariotas como a tradicional E. coli produzem maiores 
quantidades de proteína recombinante mas apresentam algumas limitações nas modificações pós-
traducionais de proteínas. Face às limitações do sistema em E.coli, a S. cerevisiae destacou-se como 
sistema de expressão heteróloga simples e robusto que permitia modificações pós-traducionais em 
proteínas. Acresce ainda o facto de ser microrganismo que reúne imensa informação acerca do seu 
genoma, é usado como modelo de estudo de mecanismos eucariotas em diversas áreas da ciência, 
teve influência preponderante na cultura e economia humana durante seculos como a produção de 
pão cerveja ou vinho, o seu estatuto GRAS e o facto de atingir grandes densidades celulares de forma 
rápida e pouco dispendiosa tornou-o rapidamente num sistema robusto e de uso rotineiro no 
laboratório. A engenharia genética é uma ferramenta interessante para melhorar as características de 
algumas estirpes já existentes, no entanto existem outras estipes de leveduras que nunca foram vistas 
ou caracterizadas, que estão escondidas por de trás da enorme biodiversidade existente em bibliotecas 
criadas a partir do isolamento de estirpes no seu meio natural. Estas bibliotecas têm um potencial 
enorme para se descobrir por exemplo novas estirpes com capacidades peculiares e melhores, novas 
enzimas, novas moléculas orgânicas entre outras. 
Este projecto, tirou partido do facto de dispor de uma libraria de leveduras isoladas de mostos 
de vinho ao longo de vários anos, à qual se fez uma seleção de estirpes com capacidade de produzir 
proteína heteróloga a níveis superiores à média. Para esta selecção criteriosa construiu-se um vetor, 
baseado no pAMT20, contendo uma alfa amílase salivar de mus musculus que serviu proteína repórter 
de actividade das colonias recombinantes, a cassete KanMX4 que é uma marca de selecção que 
confere resistência ao antibiótico G418, e uma sequência do prepro peptído responsável pela secreção 
de uma feromona com origem no K. lactis. O protocolo de transformação foi ajustado para funcionar 
em larga escala, e os testes de actividade foram avaliados como o tamanho de halos formados por 
colonias transformadas em meio solido com amido. Duas colonias de laboratório foram usadas como 
controlos no que diz respeito à quantidade de proteína produzida. Para isso fez-se uma expressão em 
meio liquido em larga escala, e purificou-se a proteína recombinante do sobrenadante e mediu-se a 
xii 
actividade. Esta actividade serviria como patamar de expressão proteica para comprara mais tarde 
com os níveis de produção de proteína recombinante de uma potencial estirpe isolada da biblioteca. 
De 400 estirpes evidenciaram se 4 estirpes que são fortes candidatos para continuar para a fase de 
validação de estirpe para expressão de proteína heterologa 
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1.1. Expression systems 
 
The expression of recombinant proteins in heterologous systems has proved invaluable for the 
determination of the biochemical and structural properties of enzymes. This is a pre-requisite for 
performing many biochemical studies and to enrich our knowledge of gene function, which too often 
relies on theories derived from sequence alignment or whole-organism genetic studies (Srivatsan, Han 
et al. 2008). Once a protein has been successfully expressed and purified, this opens the door to several 
new experiments including testing for enzyme activity, interactions studies with other proteins or 
nucleic acids, antibody generation, and ultimately structure determination (Vedadi, Arrowsmith et al. 
2010). 
The production of recombinant protein has to follow an economic and qualitative rational, which 
is dictated by the characteristics and anticipated application of the compound produced. For the 
production of technical enzymes or food additives, gene technology must provide an approach which 
has to compete with mass production of such compounds from traditional sources. As a consequence, 
production process have to be developed that employ high efficient platforms and that lean on use of 
inexpensive media components in fermentation processes. For the production of pharmaceuticals and 
other compounds that are considered for administration to humans, the rationale is dominated by 
safety aspects and a focus on the generation of authentic products (Gellissen 2006).  
Some of the systems presented are distinguished by an impressive track of record as producers 
of valuable proteins that have already reached the market, while others are newly defined systems 
that have yet to be established but demonstrate great potential for industrial applications. There is 
clearly no single system that is optimal for all possible proteins, but all have special favourable 
characteristics and limitations/drawbacks (for resumed information consult table 1). There exists 
although a correlation between the complexity of a particular protein and the complexity and 
capabilities of an expression platform. Single-subunits proteins can easily be produced in bacterial 
hosts, whereas proteins demanding presence of several disulphide bonds or authentic complex 
mammalian glycosylation necessitate higher eukaryotes as host. 
The Gram-negative Escherichia coli was the first organism to be employed for recombinant 
protein production because of its long tradition as a scientific organism, the ease of genetic 
manipulation, and the availability of well-established fermentation procedures. Typically over 90% of 
all proteins deposited in the Brookhaven Protein Data Bank (PDB) (http://www.rcsb.org) whose 
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structures have been determined have been expressed in E. coli. However, the limitation in secretion 
and the lack of glycosylation impose restrictions for general use. 
To overcome these problems a variety of expression systems have been devised. These are more 
suitable for expression of eukaryotic proteins because they possess the most appropriate chaperones 
to aid protein folding, contain homologous binding partners that may help stabilize proteins that 
naturally exist as part of a multicomponent complex, and have also the capability to perform the full 
range of post-translational modifications. These include expression in yeast, such as Saccharomyces 
and Pichia, which provide a similar intracellular environment to mammalian cells for the processing of 
proteins and require simple media and reach high cell densities (Buckholz and Gleeson 1991, Romanos, 
Scorer et al. 1992, Cregg, Vedvick et al. 1993). Filamentous fungi which have the capacity to produce 
high amounts of secreted protein and are of great use in food industry (Srivatsan, Han et al. 2008). 
Insect cells such as Spodoptera and Trichoplusia have been shown to overproduce recombinant 
proteins, generally competent in the glycosylation, and possess and efficient protein transport system 
(Matsuura, Possee et al. 1987, King and Possee 1992). Mammalian cells, [e.g., Chinese hamster ovary 
cells (CHO)] are capable of faithfully modifying heterologous compounds according to mammalian 
pattern. Animal transgenic systems are efficiently used as bioreactors for production of therapeutic 
proteins with high value for pharmaceutical use (Echelard 1996, Soler, Le Saux et al. 2005). Transgenic 
plant system offer the comfortable option to produce and store recombinant protein in certain organs 
and are easy to scale-up. Lastly, the peculiar in-vitro expression system, with the potential to produce 
otherwise toxic proteins for living cells, the cell free systems.  
All these protein expression systems will be reviewed in more detail below. Microbe have been 
used to produce a myriad of primary and secondary products to benefit mankind for decades. 
Molecular biology and genetic engineering have been the major driving force in research and the 
production of high levels of proteins, and changed the faces of pharmacology, medicine and industry. 
 
 
1.1.1. E. coli expression system 
 
The Gram-negative bacterium Escherichia coli was not only the first microorganism to be 
subjected to detailed genetic and molecular biological analysis, but also the first to be employed for 
genetic engineering and recombinant protein production. Our knowledge of its genetics, molecular 
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biology, growth, evolution and genome structure has grown enormously since the first compilation of 
a linkage map in 1964 (Neidhart 1996). 
From a model organism for laboratory-based basic research, E. coli has evolved into an industrial 
microorganism, and now the most frequently used prokaryotic expression system. It has become the 
standard organism for the production of enzymes for diagnostic use and for analytical purpose, and 
even used for the synthesis of pharmaceutical proteins, provided that the desired product does not 
consist of different multiple subunits or require substantial post-translational modification (e.g. 
Glycosylations). 
The ease of manipulation, its ability to grow rapidly to high densities in simple inexpensive 
substrates together with its well-characterized genetics made E. coli by far the most widely employed 
host. A huge body of knowledge and experience in fermentation and high-level production of proteins 
has grown up during the last 40 years. Many strains are available which are adapted for the production 
of proteins in the cytoplasm or periplasm, and hundreds of expression vectors with differently 
regulated promoters and tags for efficient protein purification have been constructed. 
 
1.1.1.1. E. coli strains 
Theodor Escherichia described back in 1885, what was to become the most widely used 
microorganism, and the cell line E. coli K12 was isolated in 1992 and deposited as “K-12” at Stanford 
university in 1925. A pedigree and description of various standard strains, including E. coli B strain, 
commonly used all over the world, was first published in 1972 (Bachmann 1972). Nowadays, many 
strains are available such as BL21 and derivatives (deficient strain in proteases), Origami (K-12 derivate, 
with mutations to enhance disulphide bond formation in cytoplasm), Rosetta (BL21 derivate, suitable 
for eukaryotic protein production with rare codons in E. coli) and many others are available to offer a 
large spectrum of features to express the desired recombinant protein. 
 
1.1.1.2. Expression vectors 
Many commercial expression systems designed for various applications and compatibilities are 
available such as the T7 based pET expression system (Novagen), systems using the λPL promoter/cI 
repressor (e.g., Invitrogen pLEX), Trc promoter (e.g., Amersham Biosciences pTrc), Tac promoter (e.g., 
Amersham Biosciences pGEX) and hybrid lac/T5 (e.g., Qiagen pQE) promoters are common (Sørensen 
and Mortensen 2005) 
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The pET expression system is the most powerful system yet developed for the cloning and expression 
of recombinant proteins in E. coli. Target genes are cloned in pET plasmids under control of strong 
bacteriophage T7 promoter and expression is induced (with IPTG) by providing a source of T7 RNA 
polymerase in the host cell. T7 RNA polymerase is so selective and active that almost all of the cell’s 
resources are converted to target gene expression and the desired  
 
 
 
  
 
 
 
 
1.1.1.3. Protein production in E. coli 
Proteins in E. coli can be produced in the cytoplasm, targeted to the periplasmic space, or as 
inclusion bodies. When targeted to the cytoplasm, protein yields are the highest and fusion proteins 
may be used to improve solubility, purification, used as reporters, or protect against degradation by 
intracellular proteases (Janiyani, Bordelon et al. 2001, Magliery, Wilson et al. 2005). There are many 
fusion partners described in literature and actively used in laboratory or industry and can be reviewed 
in (LaVallie and McCoy 1995). 
Proteins destined for the periplasmic space and outer membrane must pass through the 
cytoplasmic membrane. An N-terminal signal peptide fused to the protein is used to target proteins to 
the secretory pathway in E. coli. The periplasmic space also has its own chaperones to assist in protein 
folding and to generate disulphide bonds (Hayhurst and Harris 1999), essential to some proteins which 
cannot fold in the reducing environment of the cytoplasm, or to protect the desired product from 
proteases because periplasm itself has a different set of proteases and are less abundant (Raivio and 
Silhavy 2001). Disulphide bonds usually do not form in the cytoplasm, but mutation in target genes, 
Figure 1 – Control elements of the pET system. Schematic illustration of host and vector elements available for control of 
T7 RNA polymerase levels and the subsequent transcription of a target gene in a pET vector. T7 RNA polymerase gene is 
under the control of the lacUV5 promoter. The pLys plasmids encode T7 lysozyme, which is a natural inhibitor of T7 RNA 
polymerase, and thus reduces its ability to transcribe target genes in uninduced cells 
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which encode proteins that maintain a reductive environment, allowed for disulphide bond formation 
and some host strains (Origami) have been established.  
Inclusion bodies do have advantages of protection against proteolytic degradation, and easy 
separation and purification from other cell material (Rudolph and Lilie 1996). Heterologous proteins 
produced as inclusion bodies are inactive, aggregated and insoluble, usually possessing non-native 
intra and inter-molecular disulphide bonds and unusual free cysteine, and solubilisation steps are 
required (Fisher, Sumner et al. 1993, De Bernardez Clark 1998).  
Even being the oldest proteins expression system, it is still the most used, and developments 
and engineering strategies to improve further this prokaryotic capacity to express and process 
recombinant protein are still going on (Sørensen and Mortensen 2005). 
 
1.1.2. Other prokaryotic systems 
 
Another growing field is biotechnological engineering of gram positive bacteria such Lactic acid 
bacteria (LAB), including a large number of Gram-positive cocci or bacilli. LAB are widely used in the 
food industry for the production and preservation of fermented products. Due to their GRAS (generally 
regarded as safe) status, a great deal has been done to genetically modify them to improve their traits. 
They grow to high densities in simple media, can secrete high levels of well folded protein, and over 
the last decades a number of genetic tools have been developed for lactic acid bacteria, so homologous 
and heterologous proteins could be expressed. 
High-level production of proteins in lactic acid bacteria has been obtained using L. lactis 
constitutive promoters (Kuipers, de Ruyter et al. 1997). Several inducible expression promoters have 
been developed and through these promoters, gene expression can be controlled. The well 
characterized and commonly used controllable expression system, designed for Lactobacillus lactis, is 
the nisin-controlled gene expression (NICE) system, in which nisin serves as an inducer (De Ruyter, 
Kuipers et al. 1996, Kuipers, de Ruyter et al. 1998). The NICE system has proved to be highly versatile, 
and its use in pharmaceutical, medical and food technology fields is most promising (Le Loir, Nouaille 
et al. 2001). A similar system is also available for Bacillus subtilis, the SURE system, with the advantage 
of achieving higher expression levels are compared to NICE (Bongers, Veening et al. 2005). 
Some disadvantages mark this hosts as expression systems such as instability of plasmids or 
excessive protease secretion, which degrade the protein of interest (He, Brückner et al. 1991). But, 
some of these gram positive bacteria are used in industry in production (mainly for homologous 
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expression) of enzymes such as proteases for detergents (Maurer 2004), and amylases for starch and 
baking (Sanchez, Prim et al. 2002). 
 
 
1.1.3. Yeast Pichia pastoris 
 
The ability of certain yeast species to utilize methanol as a sole source of carbon and energy 
was discovered approximately 30 years ago by Koichi Ogata (1969). In the early 1980s, Researchers at 
SIBIA isolated the AOX1 gene (and its promoter) and developed vectors, strains, and methods for 
molecular genetic manipulation of P. pastoris (Cregg, Barringer et al. 1985, Ellis, Brust et al. 1985, 
Tschopp, Brust et al. 1987, Cregg, Madden et al. 1989). The first step in the metabolism of methanol is 
the oxidation of methanol to formaldehyde, generating hydrogen peroxide in the process, by the 
enzyme alcohol oxidase (AOX). This first step occurs in specialized organelles called peroxisomes. This 
peroxisomes sequester toxic hydrogen peroxide and keep it away from the rest of the cell. There are 
two genes that code for AOX – AOX1 and AOX2 – but the AOX1 gene is responsible for the vast majority 
of alcohol oxidase activity in the cell (Ellis, Brust et al. 1985) The AOX1 gene is tightly (at the level of 
transcription (Koichi Ogata 1969, Tschopp, Brust et al. 1987, Cregg, Madden et al. 1989) regulated and 
induced by high levels of methanol. GAP (glyceraldehyde 3-phosphate) is also one of the choice 
promoters for inducible expression. 
Pichia expression systems can either express proteins intracellularly or secreted into medium, 
benefiting the latter option from the fact that P. pastoris secretes only low levels of endogenous 
proteins (Tschopp, Sverlow et al. 1987). Vectors such as pPICZ, pHIL, pGAPZ, pFLD, and pPIC (all from 
Invitrogen) are some of the vectors available for recombinant protein expression in this system either 
for intra or extracellular expression 
Disadvantages of this system are the N-glycosylation of proteins (Hyperglycosylation), which 
differ from higher eukaryotes (Higgins and Cregg 1998, Cregg 1999, Cereghino and Cregg 2000), and 
are potentially allergenic when applied in therapeutics. 
Nevertheless it has been used as a tool in biotechnology, and to date well over 550 
heterologous proteins have been expressed in P. pastoris (see http://www.kgi.edu/faculty-and-
research/profiles/james-m-cregg.html). Significant advances in the development of new strains and 
vectors, improved techniques, and the commercial availability of these tools coupled with a better 
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understanding of the biology of Pichia species have led to this microbe’s value and power in 
commercial and research labs alike. 
 
 
1.1.4. Filamentous Fungus – Factories to secrete recombinant protein 
 
Filamentous fungi are extraordinary organisms widely impact on many aspects of our lives. 
These organisms are characterized as having branched filamentous structures or hyphae having typical 
diameters of 2–18 um, with (higher fungi) or without (lower fungi) cross-walls or septae. Higher fungi 
include Aspergillus, Penicillium, Trichoderma and Fusariumspecies. Lower fungi include Rhizopui and 
Mucorspecies. Filamentous fungi are chemo-organotrophs meaning they obtain their energy and 
carbon by oxidation of organic compounds. 
Filamentous fungi such as Aspergillus niger, Aspergillus oryzae, and Trichoderma reeseiare are 
able to produce and secrete large concentrations of enzymes into the environment (e.g. amylases, 
amyloglucosidases, proteases, cellulases, pectinases, laccases/ligninases, phytases, lipases, microbial 
rennets and glucose oxidase) (Iwashita 2002, Wang, Ridgway et al. 2005). 
The known high productivity characteristics of filamentous fungus are in parte related to their 
inherent abilities to grow at high rates and to high biomass densities supported by low cost substrates 
in relative simple fermenters. This made them especially interesting targets for recombinant protein 
production because of their demonstrated capacity to hyperproduce and secrete enzymes. As final 
products the secreted enzymes can be applied in the agricultural, food and nutrition, biomedical and 
pharmaceutical, and energy and industrial sectors (Schuster, Dunn-Coleman et al. 2002).  
Foreign genes are normally incorporated via plasmids into chromosomes of the filamentous fungi 
where they integrate stably into the chromosome as tandem repeats providing superior long-term 
genetic stability. When integrated in the fungal genome the recombinant DNA is not lost because of 
unequal partitioning, as may occur with the self-replicating plasmids used to produce recombinant 
proteins in bacteria or yeast 
Secreted yields of some heterologous proteins have been comparatively low in some cases (Iwashita 
2002). Such differences are consequence of RNA instability (Verdoes, Punt et al. 1995) and high 
protease activity (Gouka, Punt et al. 1997), and they share the same limitations in N- glycosylation’s as 
other yeasts posing a problem if this feature is required for a give protein. Recombinant protein 
concentrations have been increased by fusing the gene of interest with genes of fungal origin ((Gouka, 
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Punt et al. 1997, Punt, van Biezen et al. 2002). Such approaches have been effective with some target 
heterologous proteins but not with others 
 
 
1.1.5. Insect cell expression system 
 
Baculoviruses are insect pathogens that regulate insect populations in nature and are being 
successfully used to control insect pests. Examples include control of the codling moth, Cydia 
pomonella, on apple (Lacey and Unruh 2005), the velvet bean caterpillar, Anticarsia gemmatalis, in 
soybean fields (Moscardi 1999) and the cotton bollworm, Helicoverpa armigera (Sun and Peng 2007). 
Typical properties of baculoviruses, such as the high level of very late gene expression, make them 
highly suitable as vectors for foreign gene expression. 
In recent years, the baculovirus expression vector system has become a well-established and 
popular method for producing high yields of structurally, functionally and antigenic authentic foreign 
proteins in insect cells (Kost, Condreay et al. 2005). Traditionally, when making a recombinant 
baculovirus, the target gene is cloned into a transfer vector which contains sequences that flank the 
polyhedrin (polh) locus in the virus genome. The viruses generally used are Autographa californica 
multinucleopolyhedrovirus (AcMNPV) or in a less extend Bombyx mori (Bm) NPV. Homologous 
recombination between vector and virus genome occurs, producing recombinant budded virus which 
are harvested from the culture medium and used to infect insect cells. Some commercial expression 
systems are already in the market and used to produce recombinant protein such as flashBAC system 
(Oxford Expression Technologies Ltd), BacMagic (Merck) and BaculoOne (PAA) systems. 
The insect cells more commonly used are the Sf21 cells (O'Reilly, Miller et al. 1994), originally 
derived from the pupal ovarian cells of Spodoptera frugiperda (fall army worm), Sf9 cells (Vaughn, 
Goodwin et al. 1977), which are a clonal isolate of Sf21, and High Five cells (BTI-TN-5B1-4; Invitrogen). 
Insect cell culture medium utilizes a phosphate buffering system, rather than a carbon-based buffers 
(used in mammalian cells) and do not need CO2 incubators. 
Insect cells, have a more advanced post-translation machinery, capable of producing high levels of 
recombinant mammalian derived proteins (Agathos 1991) or proteins to use in pharmaceutical 
applications, and that they produce high levels of target proteins (Maiorella, Inlow et al. 1988). 
Insect cell systems however, do have some shortcomings such as particular patterns of post-
translational processing that differ from mammals (Bisbee 1993), some cases of inefficient secretion 
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or aggregates formation. These problems occur because it still is a recent expression system and future 
experiments and improvements will overcome these problems. 
 
 
1.1.6. Mammalian – A relative mature expression system 
 
Mammalian cells constitute a demanding system for the production of heterologous proteins. 
The need for specialized media and sufficient oxygen supply, low densities and slow growth kinetics, 
and a high sensitivity of the cells to mechanical stress are obstacles which must be overcome in routine 
fermentations (Wurm 2004). Furthermore, mammalian cells are potential targets for adventitious viral 
agents, and processes based on such cells must be rigorously monitored. Despite these difficulties, 
mammalian cells are the preferred production systems for the synthesis of authentic glycoproteins 
intended for administration to humans. 
The ease of production in bacterial systems must be counterbalanced against the need to 
dissolve and renature misfolded, aggregated, insoluble protein. In contrast, the chaperone system in 
mammalian cells ensures that proteins are secreted in correctly folded form. Whereas eukaryotic 
microbial systems such as yeasts are also capable of modifying recombinant proteins by proteolytic 
processing of precursors, formation of disulphide bridges and phosphorylation, only mammalian cells 
are able to glycosylate proteins in the patterns characteristic of higher eukaryotes, yielding products 
that are identical to their natural human counterparts (Wu, Yeh et al. 2010). 
Normally to produce recombinant proteins in mammalian cells, a coding sequence is inserted 
between a strong promoter and a polyadenylation sequence contained in an expression vector (e.g. 
pEGFPN1, Clonetech; pCMVseaphyg, ProBioGen), and transfected into the suitable cell line. The vector 
and cell line form an integrated system designed to produce maximal yields of a give protein. Cell lines 
used to produce therapeutic proteins in fermentation processes are CHO (Chinese hamster ovary), BHK 
(baby hamster kidney) and NS0 cells (mouse myeloma) and Sp2/0 (myeloma cells). More recently HEK 
293 (derived from human embryonic kidneys cells) are used for transient protein expression. The 
establishment of a recombinant mammalian production line takes a full year, therefore transient 
protein expression in mammalian cells (e.g. HEK293 and CHO) became desirable for rapid protein 
production. They produce less amount of proteins, but the levels are sufficient to satisfy screenings of 
biotherapeutics, or structural and functional studies.(Edwards and Aruffo 1993, Hanai, Nagata et al. 
2004). 
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Despite continuous advances being made in basic research for this system, the mechanisms of 
expression and secretion remain poorly understood. 
 
 
1.1.7. Trangenic animmals expression system 
 
Modern state-of-the-art molecular biological techniques allow us to transform recombinant DNA 
into fertilized animal ovum, and then these DNA components can be integrated into host genome at 
certain frequency, expressing the foreign protein in specific tissues or organs of the body depending 
on the promoters used. Up to now, a variety of transgenic animal species are being used to produce 
recombinant proteins (Echelard 1996) or being built as disease models (Fan and Watanabe 2003). 
A general approach is to target the expression of the desired protein to the mammary gland using 
regulatory elements derived from a milk protein gene and then collect and purify the product from 
milk (Clark 1998). Promoter sequences from a number of different milk protein genes have been used 
to target expression to the mammary gland, although significant problems remain with regard to 
achieving transgene expression levels consistent with commercial exploitation (van Berkel, Welling et 
al. 2002). Besides the mammary gland of transgenic animal, urine, blood, egg white, seminal plasma 
and silk worm cocoons are also for targeted protein expression. Goats, pigs, rabbit, sheep and some 
aquatic animals are being developed as production system. The individual animal expression system 
requires a relatively longer production period and higher costs than above-mentioned expression 
systems. So this system can express foreign proteins mainly for medical purposes, but not for industrial 
or environmental applications due to its relative high cost and low yield.  
 
 
1.1.8. Trangenic plant expression sytem 
 
For recombinant proteins production, the use of plants, as compared to that of living animals and 
animal cell cultures, is much safer and less expensive, requires less time, and is superior in terms of 
storage and distribuiton. 
Plants shares some architectural and functional similarities with animal cells. Hence they 
constitute and optimal system in to express heterologous proteins that require complicated post-
translational modifications, such as some glycoproteins, bioactive peptides, and drugs. In plants, 
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heterologous proteins expressed can be localized to different organs of the plant by controlling the 
tisse-specific regulatory sequences involved in gene expression. One can even maipulate the time of 
expression to specific growth stages or secrete the desired protein utilizing secretory signal sequences. 
As protein factories, plants can be grown in the field, providing a very inexpensive source of material 
(only water, minerals and sunlight) compared to any organims grown in fermenters. The scale-up is 
also very easy. More plants can be grown very easily, increasing total protein yield. Finally, expression 
of proteins in plant seeds results in a unit of production (seed) in which proteins are extremely stable, 
readily stored , and generally easier to extract and purify.  
Transgenic plants can be produced in two ways. One way is to insert the desired gene into a virus 
that is normally found in plants, such as the tobacco mosaic virus in the tobacco plant (Casper and Holt 
1996). The other way is to insert the desired gene directly into the plant DNA. plants can acquire some 
new or enhanced characteristics by the expression of target genes, such as disease resistance (Coca, 
Bortolotti et al. 2004), stress tolerance (Murakami, Tsuyama et al. 2000), enhanced growth (Holmberg, 
Lilius et al. 1997) and improving nutrition (Yoshihara, Takaiwa et al. 2005).  
This system has some disadvantages, including low transformation and expression effeciencies, 
different glycosilation pattern from that of animal-derived cell expression systems (Breiteneder, 
Krebitz et al. 2012) and a controversial safety (Schauzu 2004) 
 
 
1.1.9. Cell-Free systems 
 
Since the pioneering studies conducted by Nirenberg and Matthaei more than four decades 
ago (Nirenberg and Matthaei 1961) cell-free protein synthesis has been a valuable tool for 
understanding how mRNAs are translated into functional polypeptides. In vitro translation systems are 
based on the early demonstration that cell integrity is not required for protein synthesis to occur, and 
are also called “uncoupled translation”. In its simplest form, translation can be accomplished using a 
crude lysate from any given organism (that provides the translational machinery, accessory enzymes, 
tRNA and factors) in combination with exogenously added RNA template, amino acids and energy 
supply. 
The most popular sources of the lysates for cell-free systems are prepared based on 
Escherichia coli, wheat germ and rabbit reticulocytes. Similar to in vivo systems, the choice of the 
system should be determined by origin and biochemical nature of the protein and the specifics of the 
downstream application. Simply put, E. coli based systems provide higher yields of protein suitable for 
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structural studies (Kigawa, Yabuki et al. 1999), and Eukaryotic-based systems, which are less 
productive, provide a better platform for functional studies. (Jermutus, Ryabova et al. 1998, Endo and 
Sawasaki 2003, Jackson, Boutell et al. 2004). This is not necessary true for all cases, and thus similar to 
in-vivo systems, adjustments can be made.  
The key goal for this systems is to synthesize biological active proteins, so protein folding and 
achieving post translational modifications are the current issue. Exogenous chaperon addition to a cell 
free reaction mixture led to increase folding levels of recombinant protein (Ryabova, Desplancq et al. 
1997, Jiang, Ookubo et al. 2002). For glycosylation, developed strategies so far account for 
supplementing extracts with microsomal fractions to promote protein translocation to these 
compartments (Walter and Blobel 1982), adding non-natural amino acid linked to a monosaccharide 
moiety (works as a primer for glycosylation) along with glycotransferases (Zhang, Gildersleeve et al. 
2004) has been tested with mild results. These results however can be the drift to meliorate and 
perfectioning of the cell free systems.  
Until now, these systems have found a large variety of low and high throughput applications 
suitable for functional and structural proteomics (Kigawa, Yamaguchi-Nunokawa et al. 2002, Klammt, 
Lohr et al. 2004) and many other applications (for review see Katzen, Chang et al. (2005)). 
 
 
1.1.10. Saccharomyces Cerevisiae Expression system 
 
The Yeast Saccharomyces cerevisiae is widely recognized and used as a robust host for 
recombinant protein expression. It was the first eukaryote whose genome was fully sequenced 
(Goffeau A 1996), and has been engineered to express a wide variety of recombinant proteins for the 
last three decades. The first vaccine effective against human viral infections, hepatitis B (McAleer WJ 
1984), was produced intracellularly in recombinant S. cerevisiae. The popularity of S. cerevisiae in basic 
and applied research is undoubtedly influenced by its classification as GRAS by the U.S. Food and Drug 
Administration (FDA) and European Medicines Agency (EMEA) (Huang CJ 2010).  
This microbe provides a huge amount of information about its genetics, physiology, and 
biochemistry as well as genetic engineering and fermentation that have accumulated over time. 
Several databases such as the Saccharomyces Genome Database (http://www.yeastgenome.org/) and 
the Comprehensive Yeast Genome Database (http://mips.gsf.de/genre/proj/yeast/) contain an 
enormous amount of information concerning S. cerevisiae genes, open reading frames, and gene 
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products, as well as networks of protein interactors (General Repository of Interaction Datasets [http: 
//www.thebiogrid.org/]). The European S. cerevisiae Archive for Functional Analysis (http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/) as well as the Japanese Yeast Genetic Resource Centre 
(http://yeast.lab.nig.ac.jp/nig/index_en.html) collect and store many useful tools for the yeast 
scientific community, e.g., strains and plasmids generated during various projects 
When expressing recombinant proteins in heterologous hosts, a set of problems can appear, 
which might lead to unsuccessful results. Recent eukaryotic expression systems lack comparable 
accumulated information with regard to host physiology, genetics, proteins translation, protein 
interaction, secretion pathways etc., which can pose problems when poorly understood and become 
difficult to overcome.  
Saccharomyces accumulated data makes it an appealing host to establish an expression system 
for recombinant protein production, because much is known, and common problems have been 
solved, or can be solved with available information. Some example of products on the market which 
are made in S. cerevisiae include insulin, hepatitis B surface antigen, glucagons, granulocyte 
macrophage colony stimulating factor (GM-CSF), hirudin, and platelet-derived growth factor (Demain 
AL 2009). 
 
 
1.1.10.1. History of saccharomyces in industry 
 
In most societies, fermented beverages and foods have an important role because of their 
economic and cultural importance and the development of fermentation technologies is deeply rooted 
in their history. Archaeologists have found evidence for the production of a fermented beverage in 
China at 7000 BC (McGovern, Zhang et al. 2004), and of wine in Iran and Egypt at 6000 BC and 3000 
BC, respectively. 2003 (McGovern, Hartung et al. 1997, Cavalieri, 2003 #292). It’s tolerance to high 
ethanol concentrations (Casey and Ingledew 1986), relatively low pH and inhibitory environments of 
raw materials in large fermentation tanks (Almeida, Modig et al. 2007) made S. cerevisiae the most 
attractive microorganism, and today Baking, wine making, brewing, and production of bioethanol 
constitute the majority of S. cerevisiae biotechnological industry. Knowledge of the genetics of 
industrial yeast strains lags behind that of laboratory strains of S. cerevisiae however, there is an 
increasing interest in the functional genomics of these strains (de Winde 2003) and efforts are being 
made to improve strains to satisfy the industry demands (Nevoigt 2008). 
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1.1.10.2. Saccharomyces a model eukaryote 
 
The safety of the system is also guaranteed, including absence of endotoxins and oncogenes. In 
addition, it has proven to be a reliable model for mammalian disease and metabolic pathways, being 
frequently used as a eukaryote model to understand the role of some proteins in their native host 
(mammalian cells) (Romanos, Scorer et al. 1992), such as models is for G-protein-coupled pathway 
(Mentesana, Dosil et al. 2002). 
Apart from S. cerevisiae culture simplicity, rapid growth, and low cost, which are similar with 
those of E. coli, the possibility to express proteins into different compartments, intracellular (soluble 
or membrane bound), and extracellular, a whole set of promoters, expression vectors and other 
functional studies are available to facilitate protein recombinant expression.  
The expression cassettes can be integrated in episomal type vectors with low (CEN/ARS) or 
high copy number (2µ), allowing for different expression levels, and these vectors are generally hybrid 
between yeast-derived and bacterial sequences. The bacterial segment harbours elements required 
for plasmid propagation in an Escherichia coli host, such as an ORI and a sequence conferring resistance 
against a specific antibiotic like ampicillin. The yeast part may lean on two basic options: A first 
possibility leads to constructs which result in an episomal fate (YEp type plasmids) of the 
transformation plasmid. Such vectors replicate independently of the chromosomal DNA. 2μ plasmids 
are present in most Saccharomyces strains, making 2µ-based plasmids by far, the most used expression 
vectors in yeasts 
Alternatively, vectors are mitotically stable integrated into the host’s genome (YIp type) 
targeting the foreign DNA to specific genes of the host by homologous recombination. Integrated 
vectors are present in low copy numbers (Hinnen, Buxton et al. 1995).  
 
1.1.10.3. Genetic tools for protein expression 
 
Yeast mRNA promoters consist of at least three elements which regulate the efficiency and 
accuracy of initiation of transcription (Struhl 1989). Upstream activation sequences (UASs), TATA 
elements and initiator elements. It is advantageous to use yeast-derived (homologous) rather than 
heterologous sequences, because the former are more efficient and heterologous elements will 
sometimes not work in yeast. Constitutive promoters are derived from genes of the glycolytic pathway, 
because these lead to high-level transcriptional expression. On the other hand, regulated promoters 
can be controlled by controlling the availability of certain nutrients. This allows to increase yeast cell 
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mass prior to heterologous gene expression, so that the cell population can be optimized before the 
regulated promoters are turned on.  
The first promoters used were from genes encoding abundant glycolytic enzymes in yeasts like, 
alcohol dehydrogenase I (ADHI) (Hitzeman, Hagie et al. 1981), phosphoglycerate kinase (PKG) 
(Hitzeman, Leung et al. 1983), glyceraldehyde-3-phosphate dehydrogenase (GPD) (Bitter and Egan 
1984) or pyruvate kinase (PYK1), These promoters are constitutive, their activity may be 
enhanced/induced by addition of glucose to medium and despite being poorly regulated, and they are 
the most powerful of S. cerevisiae. 
On the other hand, Galactose promoters (GAL1 and GAL10) are the most powerful tightly-
regulated promoters of S. cerevisiae. The genes encoded by the GAL family are involved in metabolizing 
Galactose, they remain tightly repressed in the presence of glucose and are induced by galactose. 
Manipulations in order to improve the Galactose-regulated system have been carried to enhance the 
expression of heterologous genes, but thigh regulation was lost (Baker, Johnston et al. 1987). Some 
strategies fused GAL promoters to glycolytic to combine thigh regulation of GAL, with the high activity 
of glycolytic promoters (Partow, Siewers et al. 2010). 
Another well studied and well regulated gene is the promoter of the acid phosphatase (POH5). It 
is negatively regulated by inorganic phosphate and switching to a low-phosphate medium induces the 
promoter. Since the PHO5 promoter is not very strong, relative to glycolytic, its effective regulation 
trough POH5 has also been used to confer regulation to glycolytic promoters (Hinnen, Meyhack et al. 
1989). MET3 and CUP1 are another example of negatively regulated promoters, by methionine and 
Ca2+ ions respectively (Mascorro-Gallardo, Covarrubias et al. 1996, Mao, Hu et al. 2002). 
Repressible and strong promoters examples are the ADH2 (Alcohol dehydrogenase II, both 
powerful and tight regulated), SUC2 and CYC1 (CYC1 is a weak promoter) which are repressed by 
glucose presence in the medium (Price, Taylor et al. 1990). However this is a disadvantage in industrial 
processes, because maintaining high concentrations of glucose are expensive and difficult because of 
high cell density. Galactose regulated promoters also have a disadvantage in industrial processes, 
because of the need to add inducer to the medium, which is not economically compatible with large 
fermentation tanks. 
Selection markers are another important component present in an expression vector, and yeast 
selections usually relies on complementation selection. It explores the host incapacity to synthetize a 
specific organic molecule (auxotrophic selection), essential for growth, such as LEU2, TRP1, URA3 or 
HIS3 which encode for leucine, tryptophan, uracil and hisitdine respectively. Another type of selection 
possible for yeasts is the use of antibiotics, also called dominant selection, and some examples of 
frequent use are the aminoglycoside antibiotic G418 (Agaphonov, Romanova et al. 2010), hygromycin 
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B (Gritz and Davies 1983), chloramphenicol (Hadfield, Cashmore et al. 1986), and neomycin (Prezant, 
William jr et al. 1996). 
 
One appreciated feature of recombinant protein expression systems is ability in secretion of 
the target protein to facilitate purification and separate from all the cell material. The enriched 
endomembrane system of yeasts allows proteins to be secreted into the extracellular environment, as 
well post-translational modifications that are sometimes required to produce active recombinant 
protein S.Cerevisiae only secretes naturally 0.5% of its proteins, but it can be increased several fold so 
that secreted proteins are almost free of contaminations with other cell material. As higher eukaryotes, 
protein secretion of yeast is directed by an amino-terminal sequence (secretion signal sequence) that, 
targets proteins to surface, to a vacuole or are excreted. The well-studied leader to secrete 
saccharomyces cerevisiae mating pheromone, prepro-sequence of MFα1, is extensively used with 
reports of efficient secretory activity. Tags fused to proteins in S. cerevisiae normally serve the purpose 
of purification, or detection assays, such as GFP (Niedenthal, Riles et al. 1996). 
 
1.1.10.4. S. cerevisiae Transformation 
 
Genetic transformation of Saccharomyces cerevisiae, was first reported by Oppenoorth 
(Oppenoorth and van 1960) but until today, several techniques have been developed, with high 
efficiency of transformation and ease of manipulation. The removal of yeast cell wall by enzymatic 
treatment, using gut juice of snail” to yield protoplasts was first observed in 1957 (Eddy and Williamson 
1957). But transformation of yeast cells with recombinant DNA became feasible for the first time in 
1978 by treating spheroplasts with calcium and PEG (Hinnen, Hicks et al. 1978). Years later, intact yeast 
cell transformation was achieved and along came an innovating technique, which used monovalent 
cations in combination with PEG and a heat shock at 42 ºC to stimulate DNA uptake by yeasts (Ito, 
Fukuda et al. 1983). Today, different methods exist and are employed according to need. The 
LiAc/ssDNA/ PEG method (improvement from the original Li+ method) is the most widely used with 
highest efficiencies, Electroporation is fast and easy to manage (Dower, Miller et al. 1988), Glass bead 
method, with lower yields but very simple and low cost (Costanzo and Fox 1988), biolistic 
transformation (Sanford 1988) and spheroplasting used to transform YACs (Burgers and Percival 1987) 
are the main techniques used in routine transformations of yeasts. 
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1.1.10.5. S. cerevisiae post-translational modifications 
 
S. cerevisiae, can secrete recombinant proteins to the culture medium, intracellular proteins 
are usually properly folded, and as other eukaryotes, it is also capable of performing most 
posttranslational processing typical of mammalian cells. However, differences in glycosylation in 
proteins expressed in yeast, compared to those of mammalian cells, limit their use. N-glycosylation of 
proteins produced by yeasts are high-mannose (with more than 3 mannose residues) or hypermannose 
(more than 6 mannose residues) types, with terminal α-1, 3 linkages (Gellissen 2000). Such forms are 
very immunogenic to mammals (Ko, Hahm et al. 2002). Moreover, O-glycosylation by yeasts contains 
only mannose residues (Gellissen 2000). Cell engineering has been utilized for obtaining 
nonimmunogenic glycoproteins from yeasts. Namely, Chiba et, al. introduced the gene of a α1, 2-
mannosidase with an ER retention signal in a S. cerevisiae mutant that had disrupted the genes of 
several mannosyltransferases (Chiba, Suzuki et al. 1998). Unmodified yeasts are suitable for the 
production of proteins that do not require mammalian-type glycosylation. 
Another important molecular aspect of recombinant proteins expressed in yeast are the 
features of post-translational processing and modification processes specific to yeast, which provide 
an eukaryotic mechanism to fold and modify proteins. Moreover, intracellular proteins are usually 
properly folded. As other eukaryotes, yeasts are also capable of performing most posttranslational 
processing typical of mammalian cells 
Unmodified yeasts are suitable for the production of proteins that do not require mammalian-
type glycosylation. One of these proteins is insulin, which has been commercially produced in S. 
cerevisiae after enhancing its folding and secretion capacities through genetic engineering (Kjeldsen 
2000). 
New yeast strains, never described before, with peculiar features are also a good to propel the 
establishment of an expression system. Recent progress in molecular microbial ecology has shown that 
microbial diversity is far greater than that reflected in laboratory strain collections (Courtois, 
Cappellano et al. 2003). Microorganism libraries have huge biodiversity, and recent studies have begun 
to confirm the enormous potential for discovering new enzymes small molecules or strains with 
enhanced capacities (Short 1997, Rondon, August et al. 2000). Biodiversity in libraries of wine making 
Saccharomyces cerevisiae is starting to get interest because of the potential they represent in the wine 
industry (Valero, Cambon et al. 2007), but this does not mean that other potentialities, such as good 
hosts to establish as protein expression systems, might advent from screenings.  
Recombinant DNA expression constitutes a major approach in gene function studies that 
naturally complement genetic and genomic research. Well-regulated expression systems provide an 
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invaluable tool for investigating the cellular roles of novel genes either in their original cellular 
environment or in specialized host organisms (Porro, Sauer et al. 2005). These systems can be utilized 
to observe the biological effects of the controlled expression (or lack of it) of a given DNA sequence. 
Very often they also provide the means to produce and purify a desired gene product, opening the way 
to a comprehensive analysis and manufacture of proteins of biotechnological interest (Quintero, Maya 
et al. 2007). 
All expression systems have advantages and limitations, and the variety of systems available 
allow to compensate each other’s flaws, overcoming problems in this area of science, to the benefit of 
mankind. Table 1 and 2 resume the features of the main expression systems used today.  
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Table 1 Characterization of expression system in common use 
Host 
system 
 Cell 
growt
h 
Cost 
mediu
m 
Expressio
n level 
Post-translational modifications  
 
Protein 
folding 
N-linked 
Glycosylatio
n 
O-
linked 
Glyc. 
Phosphorylat
ion 
Acetylatio
n 
Gamma-
carboxylatio
n 
E.coli 
 Rapid 
(30 
min) 
Low High 
Refoldin
g usually 
required 
None No No No No 
Yeast 
 Rapid 
(90 
min) 
Low Low-High 
Refoldin
g may be 
required 
High 
mannose 
(mostly) 
Yes Yes Yes No 
Insect cells 
 Slow 
(18-
24h) 
High Low-High 
Proper 
folding 
Simple, no 
sialic acid 
Yes Yes Yes No 
Mammalia
n 
cells 
 
Slow 
(24h) 
High 
Low-
moderate 
Proper 
folding 
Yes Yes Yes Yes Yes 
Adapted from (Yin J 2007) 
 
 
 
Tabela 1 - Applications of expression system in common use 
Host system Advantages Disadvantages Common applications 
E.coli Scale-up, low cost and time, 
easy operation 
Protein solubility, may require 
protein-specific optimization 
Structural analysis, antibody generation, 
funtional assays, proteins interactions 
Yeast Eukaryotic protein 
processing, scalable up to 
fermentation simple media 
requiremens 
Fermentation require for very 
high yield, growth conditions 
may require optimization 
Structural analysis, antibody generation, 
funtional assays, proteins interactions 
Insect cells Near mammalian protein 
processing, greater yield 
than mammalian system 
More demanding culture 
conditions 
funtional assays, proteins interactions, antibody 
generation 
Mammalian cells Highest level protein 
processing 
Relatively low yield, more 
demanding culture condition 
Funtional Assays, proteins interactions, antibody 
generation 
Adapted from (Yin J 2007) 
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1.2. Objectives 
 
Saccharomyces cerevisiae is a robust microorganism used for decades all over the world for 
recombinant protein expression. On the other hand, libraries of Wine making S. cerevisiae harbour 
immense potential and huge biodiversity of yeast strains. Regarding this, the main objective of this 
work was to establish a high throughput screening method to research the biodiversity of a S. 
cerevisiae library isolated from wine practice over the years, and ultimately to isolate potential 
candidates for further characterization, to be validated as recombinant protein expression systems to 
enrich the laboratory means, and further away, to use in industry  
 
 
 
 
 
 
 
 
 
 
Materials and methods 
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2.1. Material and methods 
The majority of reagents used in the following procedures were obtained either from Sigma-
Aldrich or Merck. DNA inserts were obtained from different plasmids, purchased or availiable in the 
lab. KanMX4 cassette came from pUG6 vector, P.pastoris αMating factor secreting leader (αMF) from 
pPICKzαA, K.Lactis’s αMF from pKLAC-1, α-Amylase (AMY) was purchased from Source Bioscience 
(Unigene ID: Mm.439727) and pAMT20 vector (Fig.3A) was kindly provided by Iha, Hidekatsu (Iha and 
Tsurugi 1998). Commercial yeasts used in this work were two lab strains, MATa/MATα W303 (leu2-
3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11, 15) and CEN.PK2 (MATa/α ura3-52/ura3-52 trp1-
289/trp1-289 leu2-3_112/leu2-3_112 his3 Δ1/his3 Δ1 MAL2-8C/MAL2-8C SUC2/SUC2). The Yeast 
library was created out from Alentejo, Bairrada, Douro and Dão Portuguese Appellations, by isolation 
of S. cerevisiae from wine yards, wine tanks, and fermentations performed in laboratory, during several 
consecutive years 
 
 
2.2. Methods 
2.2.1. PCR 
 
Majority of PCR reactions were performed using, NEB Phusion® High-Fidelity DNA Polymerase 
(1 U), 0.5 µM of each primer (forward and reverse), 200 µM dNTP’s, 1x Phusion HF buffer. The PCR 
conditions were: initial denaturation 95 ºC during 5 min, followed by 35 cycles of denaturation 98 ºC 
during 20 seconds, annealing at 3 ºC under Tm during 30 seconds, extension at 72 ºC at a rate of 30 
seconds per kb, a final extension at 72 ºC during 7 min, and stored at 4 ºC until further use. For ligation 
reactions in pGEM-T Easy, PCR reactions were performed using, GE Healthcare Taq DNA Polymerase 
(1.U), 0.2 µM of each primer, 200 µM dNTP, 1x rTaq DNA polymerase buffer. The PCR conditions were: 
initial denaturation 95 ºC during 2 min, followed by 35 cycles of denaturation 95 ºC during 30 seconds, 
annealing at 5 ºC under Tm during 30 seconds, extension at 72 ºC during at a rate of 1 min per kb, a 
final extension at 72 ºC during 10 min, and stored at 4 ºC until further use. 
 The bands of each amplified DNA insert were gel purified using Invitrogen PureLink® Quick Gel 
Extraction Kit according to manufacturer’s instructions. 
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 Table 2 – Sequence of primers used in sequence-independent cloning. DNA fragment number (Fnº). Primers are represented 
in 5’ to 3’ direction. The primer hybridization zone to the correspondent gene is underlined Fnº and numbers above and 
below the underline correspond to Fnº. Grey boxes represent the overhangs designed in primer. Numbers below and above 
grey boxes illustrate the matching overlapping sequences. Exception is between insert nº 2 and nº3, where a His-tag designed 
in the primers (C-terminal tag) is the overlapping sequence. Asterisk represents the stop codon 
 
 Table 3 – Sequence of Primers used for digestion-ligation cloning. Primers are represented in 5’ to 3’ direction. Restriction 
sites are marked in bold. “F” stands for forward and “R” for reverse 
 
 
Gene/DNA 
insert 
Fnº Primer 
name 
Sequence        
        
α-Mating 
Factor 
1 F1_F 
 
 
F1_R 
5’-TCA ACT CCA AGC TGA CTC TAG ATG AGA TTT CCT TCA ATT TTT ACT G-3’ 
 5                         XbaI  1    
           2    1 
5’-GGT CAT ATT GAG CTT CAG CCT CTC TTT TCT C-3’              
α-Amylase 
2 F2_F 
 
 
F2_R 
5’-GG CTG AAG CTC AAT ATG ACC CAC ATA CTC AAT ATG-3’ 
 1   2 
      *  His Tag   2 
5’-TCA GTG ATG GTG ATG GTG ATG TAT TTT TGA CTC TGC ATG GAT T-3’ 
ADH1 
terminator 
from 
pAMT20 
3 F3_F 
 
 
F3_R 
5’-CAT CAC CAT CAC CAT CAC TGA GTC GAC CTG CAG CCA AGC TAA TT-3’ 
 His Tag     *  3 
 4    3 
5’-GAG GCA AGC TTA GGT TAT TAC TGA GTA GTA TTT ATT TAA GTA TTG TTT-3’ 
KanMX4 
cassette 
4 F4_F 
 
 
F4_R 
5’-CTC AGT AAT AAC CTA AGC TTG CCT CGT CCC-3’ 
 3      4 
 
4  5 
5’-CGT GAG TAT ACT CGA CAC TGG ATG GCG-3’ 
pAMT20 
backbone 
5 F5_F 
 
 
F5_R 
5’-TCC AGT GTC GAG TAT ACT CAC GTG CTC AAT AGT CAC-3’ 
 4   5 
 1                   XbaI      5 
5’-GAA GGA AAT CTC ATC TAG AGT CAG CTT GGA GTT GAT TGT-3’ 
Primer name Sequence 
KanMX4-Nde_F  
 
 
KanMX4-Bsr_R  
5’-GGG AAT TCATATGAGCTTGCCTCGTCCC-3’ 
NdeI   
    BsrGI 
5’-GGG AAT TCT GTA CAT TAA GGG TTC TCG AGA GCT C-3’ 
pAMT20-Bsr_F 
 
 
pAMT20-Nde_R 
5’-GGG AAT TC TGT ACA TAT ACT CAC GTG CTC AAT AGT CAC-3’ 
   BsrGI 
NdeI 
5´-GGG AAT TCC ATA TGT AGG TTA TTA CTG AGT AGT ATT TAT TTA AGT ATT GTT T-3’ 
αMF-pKlac-Bam-F 5’-GGATCC ATG AAA TTC TCT ACT ATA TTA GCC GC-3’ 
BamHI 
Amylase-Bgl-F 
 
 
Amylase-Sal_R 
5´-AGA TCT CAA TAT GAC CCA CAT ACT CAA TAT G-3’ 
BglII 
SalI 
5’-GTC GAC TCA GTG ATG GTG ATG GTG A-3’ 
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2.2.2. CPEC cloning 
 
All DNA inserts used in CPEC procedures were amplified using New England Biolab (NEB) 
Phusion® High-Fidelity DNA Polymerase and primers listed in Table 1. For cloning of all PCR products, 
50-150 ng linearized vector (longest PCR product) was mixed with all amplified DNA insert to a final 
ratio of 1:1 or 1:2 (vector:insert). Additionally, Phusion polymerase (1 U), 200 µM dNTP and 1x Phusion 
HF buffer were added. CPEC conditions were: initial denaturation 95 ºC during 10 min, followed by 25 
cycles of denaturation 98 ºC during 20 seconds, annealing at 55 ºC during 30 seconds, extension at 72 
ºC at a rate of 30 seconds per kb according to length of the longest piece, a final extension at 72 ºC 
during 10 min, and correct size product formation confirmed in agarose gel. 
 
 
2.2.3. Gibson Assembly™ and In-Fusion®HD  
 
Purified PCR products used for these procedures are the same as for CPEC cloning. Gibson 
assembly was performed in a total volume of 20 µl using: Gibson Assembly Master Mix (1x), 0.2 ρmol 
for PCR products longer than 1500 bp, and 0.4 ρmol for PCR products with less than 1500 bp Reaction 
is incubated at 50 ºC during 60 min in a thermocycler, and final product with the correct size confirmed 
in agarose gel or used for transformation procedure. 
For In-fusion, following quantities were used; total volume of 20µl with 1x In-Fusion HD 
Enzyme Premix, 50 ng for PCR products longer than 1500 bp, 75 ng for PCR products between 1500-
500 bp, and 30 ng for PCR products with less than 500 bp Volume reaction is incubated at 50 ºC during 
15 min, followed by transformation procedures. 
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2.2.4. Vector assembly. Restriction-Ligation cloning 
 
All sub-cloning reactions in pGEM®-T Easy Vector used Taq polymerase (GE Healthcare) to 
generate PCR products (primers listed in table 2). Ligation procedures on pGEM-T Easy were performed 
using NEB T4 DNA Ligase (400 cohesive end U), 1X T4 DNA Ligase Buffer, 25ng pGEM-T east vector, and 
75 ng insert DNA. Positive clones were selected by blue/white selection on agar plates with 40 µl of 
100 mM IPTG and 25 µl of 50mg/ml X-gal (X-gal and IPTG were spread over the surface of an LB-
ampicillin plate and allowed to absorb for 30 minutes at 37°C prior to use.) and analysed by restriction 
analysis with endonucleases and automated DNA sequencing. 
 For ligations not involving pGEM-T easy, procedures were as follows: T4 DNA ligase (400 
cohesive end U), 1X T4 DNA Ligase Buffer, 1:3 Vector: insert ratio using 100 ng digested vector. 
Incubation times for all ligations were always performed at 16 ºC O.N. in a water bath. 
All restriction analyses were performed using NEB endonucleases enzymes, and NEB buffer 
selection was set according to NEB Double Digest Finder tool. Incubation were always set at 37 ºC 
during 3-4 hours, 1 x NEB buffer (1, 2, 3 or 4), restriction enzymes (6U), and BSA (1 x) when needed. In 
the case of vectors, after double digestion procedure, CIP (5U) were added to the reaction tube, further 
incubated during 2 hour and purified using Invitrogen PureLink-quick gel extraction kit. DpnI assays 
procedures were performed as follows: DpnI enzyme (40 U) and 1x NEB buffer, followed by liquid 
purification using Invitrogen PureLink-quick gel extraction kit. Automated sequencing was performed 
either in STAB Vida of MACROGEN. 
 
 
2.2.5. Saccharomyces deep well preparation 
 
Prior to transformation, Saccharomyces library was prepared as following: First, each strain 
from a main stock (kept at -80 ºC) was streaked on YPD agar and grown O.N.. at 30 ºC. Then, a single 
colony from each strain was picked and inoculated in a single well (with 800 uL of YPD medium) of a 
96 deep well plate, so each well contains a diferent strain. After completed, an over nigh incubation at 
30 ºC in a static incubator (Binder BD115 #05-91700) follows, cells are counted (using a Automated cell 
counter TC10® from Bio Rad) and a new deep well is prepared with 1*10^5 cells per well and stored at 
4 ºC until further use. 
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2.2.6. Carrier DNA preparation 
 
Carrier DNA (2mg/ml) was extracted from liofilized salmon testis. Dissolved DNA (10 mg/ml), 
it is incubated with Proteinase K (2 mg/ml) for 3-4 h, and extracted twice with a 24:1 chloroform: 
isoamyl alcohol solution, followed by precipitation at a 1:10 ratio with a 5 M NaCl solution, 2.5 volumes 
of 96 % ethanol and let to rest at 4 ºC O.N. After precipitation DNA is centrifuged at 14000 x g for 10 
min, washed with ethanol 70 % (to remove excess salt), centrifuged again to remove ethanol and dryed 
at 37 ºC. DNA is resuspended using ddH2O at 2mg/mL concentration, aliquatoed, boiled at 98 ºC for 20 
minuts and stored at -20 ºC. Prior to use, aliquots are boiled for 5 minuts and chilled on ice. 
 
 
2.2.7. Yeast medium sclae tranformation 
 
Several colonies, with less than two weeks, with 2-3mm diameter were inoculated in 1mL YPD, 
vigorously vortexed and transferred to an Erlenmeyer flask containing 50 mL YPD. Culture medium was 
grown O.N. in a rotary shaker (Innova 44 - incubator shaker series) at 30 ºC and 200 rpm. The next day, 
culture was diluted in 100 mL YPD medium to an OD600 of 0.2 and grown with agitation at 30 ºC and 
200 rpm approximately 3-5 hours. When OD600 reached 0.5-0.6, cells were pelleted at 1000 x g for 5 
minutes at room temperature. Supernatant was carefully removed, each pellet resuspended in a total 
of 12.5 ml of freshly prepared TE/LiAc buffer [(10 mM Tris-HCl pH 7.5, 1 mM EDTA, 100mM lithium 
acetate (LiAC)], and pooled into one tube. Cells were pelleted again, resuspended in 500 µl of TE/LiAc 
buffer, and aliquot (150 µl) in Eppendorf tubes. 
For transformation procedures 0.5 µg plasmid DNA is added to a single aliquot, following 600 µl of 40 
% of PEG solution (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 100mM LiAc, 40 % PEG). Cells are carefully 
mixed, and incubated for 45 min in a rotary shaker (Innova 44 - incubator shaker series) at 30 ºC and 
200 rpm. After incubation DMSO is added (final concentration of 10 % v/v), tubes are gently mixed by 
inversion. Heat shock was performed at 42 ºC in a water bath for 1 h, and cells chilled on ice. 100 or 
200 µl of the cell mixture is plated on selective plate and placed at 30 ºC in a static incubator for 3-5 
days until large colonies are formed. Alternatively, before plating a Recovery step at 30 ºC and 200 rpm 
in a rotary shaker may be performed to increase number of transformants. 
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2.2.8. 96-well Microtiter tranformation 
 
Yeast transformation was performed according to (Gietz and Schiestl 2007) with some 
modifications. Deepwell plates were prepared as described in previous section were grown overnight 
and 200 μl off each well were transferred to a 96 well microtiter plates with the help of a multichannel 
pipette. This results in 10^6 – 10^7 order of cells per well. Cells were pelleted at 2000 x g for 30 min 
and supernatant was removed with a single shake. All single shake procedures should be performed 
into a large recipient with paper covering the bottom to avoid splashing. 
When peparing the transformation mix without PEG, plasmid DNA was used in 1 - 1.7µg per 
well, all ressuspending steps were performed at 400 rpm using a microtiter box in a rotary shaker 
(Infors HT Ecotron - AG-CH4103 Bottmingen) at 30 ºC. Heat shock was performed fo 3 hours, at 42 ºC 
with multiwell plates inside zipped plastic bags. After heat shock the cells were plated at 1500 x g for 
10 min and supernatant removed with a single shake. Cells were resuspended in 50 ul 35 % PEG 
solution and rested for 1h. After 1 hour, 150 ul YPD without selection marker was added to each well 
and incubated O.N. at 30 ºC. Finally the 200 μl from the 96-well microtiter plate are transferred to a 
deep well with 600 μl YPD + 200 ug/mL of the antibiotic G418 and incubated at 30 ºC for 3-5 days. 
 
2.2.9. High throughput activity assay 
 
High troughput assays were performed in a Sciclone ALH 3000 Workstation-Caliper LifeScience 
robot, with a 96 pin tool. Pin tool was sterilized as followed : First, dippind 3 x in 10 % beleach and 
dryed by touching a lint free blotting paper, followed by dipping in a water tank, sonicated for 50 
seconds, removed and dipped 3 x in the same water (while sonication is on) and dryed out in lint free 
blotting paper. Finally, the 96 pin tool is dipped 3 x in 96% ethanol and air dryed. For halo assays, 1 μl 
of culture medium were transferred with the sterelized pin tool to a single well (Nunc® OmniTray 
Single-Well Plates with Lids, Thermo Scientific) containing YPD agar supplemented with 2% starch, 200 
μg/ml G418 and grown O.N. Plates were stained with a solution of 70 % lugol to see halo formation. 
Lugol contains iodine which is capable of inserting itself inside the 3 dimensional structures of starch 
mixed in the solid medium. If starch is degraded, iodine is unable to be retained in solid medium and 
no staing occurs in the area. 
 
Chapter 2 45 
 
2.2.10. Small-scale screening for protein expression 
 
In the small-scale screening of protein expression, a single colony with 2-3 mm diameter was 
scraped from the plate and resuspended in 10 mL YPD medium supplemented with 200 µg/mL G418, 
and grown in a rotary shaker at 30 ºC and 200 rpm (Innova 44 - incubator shaker series) O.N... The next 
day, starter culture was diluted in 30 mL YPD medium supplemented with 200 µg/mL G418 to an O.D. 
of 0.2 in 100 ml baffled Erlenmeyer flasks. The first sample (250 µl) was collected when OD600. reached 
0.8, and subsequent samples collected two times a day, in the morning and evening. Samples were 
collected during 72 hours and were immediately denatured in 6x denaturing buffer and stored at room 
temperature until further use. 
 
 
2.2.11. Protein Expression and Purification 
 
For large-scale cultures, first a single colony (never older than two weeks) was inoculed into 
20 mL YPD medium containing 200 μg/μl G418 and grownh for 6 to 8 hours. Then the wole inoculum 
was poured into 30 ml YPD medium (with 200μg/μl G418) and grown with agitation at 30 ºC and 200 
rpm. Next day, the culture was diluted to an O.D. of 0.2 into 4 x 2.5 L Thomson Ultra Yield Flasks 
containing 1 L YPD medium each with 60 μg/μl G418, and let to grow during 120 hours in a rotary 
shaker at 30 ºC and 200rpm. 
After culture was grown, cells were pelleted by centrifugation at 5000 x g for 20 min at 4 ºC, 
and supernatant was carefully removed. Each pellet was resuspended in a total of 10 mL of 20mM 
phosphate pH 7.5 buffer with 100 mM NaCl and pooled togheter. Resuspended cells were lysed in a 
Emulsiflex-C3 from Avestin (3 passages at 21000 psi), the lysed cell extract was ultracentrifuged at 
104350.1 x g and supernatant was stored at -20 ºC. 
The supernantant was concentrated by Tangential Flow Filtration (Sartocon® Slice 200) using 
a 10 kDa membrane down to 200 ml and ultracentrifuged at 104350.1 x g. Protein was precipitated 
with 90 % ammonium sulphate in an ice bath (0 ºC) with agitation (salt concentration was calcluated 
using http://encorbio.com/protocols/AM-SO4.htm calculator), centrifuged at 10000 x g for 20 min, 
resuspended in 10 ml of 20 mM phosphate pH 7.5 buffer with 100 mM NaCl and filtred with 0.2 μm 
membrane. Filtred fraction was applied to size exclusion chromatography Superdex 200 26/60 prep 
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grade (GE Healthcare Life Sciences), previously equilibrated in 20 mM phosphate pH 7.5 buffer with 
100 mM NaCl. The column was operated in a AKTA FPLC system (GE healthcare Life sciences) at a flow 
of 2 ml/min at room temperature, and 10 mL fractions were colected and immediately stored at 4 ºC 
until further use. 
 
 
2.2.12. SDS-PAGE and Western Blot analysis 
Protein samples were loaded with 6 x loading buffer (0.35 M Tris-HCl/0.28% SDS buffer pH 6.8, 
30% glycerol, 10% SDS, 0.6 M DTT, 0.012% Bromophenol Blue), denatured at 90 ºC for 10 minutes and 
separated by SDS-PAGE. . The SDS-PAGE was done in 12.5 % polyacrylamide gels and run at 150 V at 
room tempeature, until the dye (Bromophenol blue) exits the gel, using a MiniProtean 3 system (Bio-
Rad). The running buffer was 100 mM Tris, 100 mM Bicine with 0.1 % SDS. The gels were stained with 
a solution containing 50 % methanol, 10% acetic acid and 0.2 % Coomassie Brilliant blue. The removal 
of the excess staining was accomplished by incubation with a solution containing 25% methanol and 
5% acetic acid under agitation at room temperature. 
For Western blot analysis, protein separeted by SDS-PAGE were transferred to a PDVF 
membrane (Roche), previously activated in methanol. The electrotransferences were performed in a 
Trans-Blot® Electrophoretic Transfer Cell (bio-rad) or in Bio-Rad Mini Protean® tetra system. For Trans-
Blot® Electrophoretic Transfer Cell, overnight electrotransferences at 40 V, 11 ºC were performed using 
25 mM Tris, 192 mM Glycine and 20 % methanol. Electrotransferences in the mini system were 
performed either for 2 hours (electrotransference at 100 V, 11 ºC using 10 mM CAPS pH 11 with 10 % 
methanol) or or overninght at 30 V, 11 ºC using 25 mM Tris, 192 mM glycine and 20 % methanol. 
After transfer, PDVF membranes were blocked with TBST buffer (20 mM Tris, 137 mM NaCl, 
0.1 % Tween, pH 7.6) containing 5 % skim milk for 1 hour. The membrane were then incubated for 
another hour with the primary antibody against His-Tag (THETM His Tag Antibody, mAb, Mouse, 
GenScript) diluted in TBST 0.5% milk solution (1:10000 dilution). After the first incubation, the 
membrane was washed with TBST 0.5% milk solution at least 7 times for 5 minutes before incubation 
with secondary antibody. Incubation with the secondary antibody also lasts 1 hour, in the same 
solution (TBST 0.5% milk). Secondary antibody used is a Anti-Mouse IgG + IgM alkaline phosphatase 
linked whole antibody (from goat; Amersham Biosciences) with the same dilution (1:10000). 
Membranes were washed at least 7 times for 5 minuts with TBST buffer, then developed with ECF TM 
substrate (GE Healthcare) for 5 minuts, and revealed in a Molecular Imager FX (Bio-Rad) scanner. 
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2.2.13. Enzyme activity assay 
 
Agar plates were prepared with 50 mM Hepes pH 6.9 buffer, 5 mM CaCl2, 2 % starch and 20 g/L 
agar. After solidification, holes were opened in the agar with the help of a 60 mL plastic syringe 
(without needle) and 15 to 20 μl samples loaded into each holes. Plates were incubated overnight at 
30 ºC and stained with 70% lugol solution. Activity was measured as the ratio of the halo/colony size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results and Discussion 
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3.1. Vector assembly 
 
To screen a wine yeast library with vast biodiversity in S. cerevisiae strains, for candidate hosts 
to establish a recombinant protein expression system, an effective and high throughput assay had to 
be assembled. The screening needed to simple, fast, and one of the best strategies to perform this is 
testing activity on agar plates. This method provides a quantitative assay, simple, inexpensive, straight 
forward method to assess the activity of enzymes (Vermelho, Meirelles et al. 1996). Iodine, contained 
in I2KI solution (e.g. Lugol), is capable of inserting itself between the secondary structures of starch 
mixed in agar plates, acquiring a dark blue colour. But if starch is degraded, iodine is not held in the 
agar because the secondary structure of starch is lost, and no staining occurs. Salivary α-Amylase has 
such capacity and can be adapted to a high throughput screening, when for instance, is secreted from 
recombinant yeast grown on solid medium. Variable sized halos will form around colonies, depending 
on the protein production capacity of yeasts, allowing for a simple way to differentiate potential 
individuals to establish an expression system. 
Mus musculus salivary α-amylase mature form (without native signal peptide) was the enzyme 
chosen for the activity assay. The α amylase family contains a characteristic catalytic (β/α)8-barrel 
domain, depends on Ca2+ ions to be active and has two potential glycosylation sites. It has been 
previously successfully expressed and secreted in an active form from yeasts (Thomsen 1983, Kato, 
Ishibashi et al. 2001) and presents itself as two bands in SDS-PAGE, 57 and 60 kDa for non-and 
glycosylated form respectively. 
To complete the screening method, a selective marker is needed to exclude non transformed 
strains. Normally, selection in yeasts is based in complementation for defective amino acids 
(auxotrophic selection), but wine yeast are normally prototrophic (Hammond 1995, Benítez, Gasent‐
Ramírez et al. 1996, Guijo, Mauricio et al. 1997, Pretorius 2000, Dequin 2001) and thus, a dominant 
marker that confers resistance to an antibiotic was used. KanMX4 cassette confers resistance to 
Kanamycin in E. coli and to G418 antibiotic in yeasts (Agaphonov, Romanova et al. 2010). 
Finally, pAMT20 is the vector backbone which will incorporate these genes used in the high 
throughput screening. It is a 2µm based E. coli/yeast shuttle vector with high copy number in both 
organisms, it has a strong glycolytic promoter (short version of ADH1) and a terminator to stop 
transcription (tADH1). An inducible promoter would not be adequate for a high throughput screening 
because of technical difficulties of the process per se. The short version of ADH1 promoter, is reported 
to be fully activated only when glucose is almost depleted from medium, but remains active through 
52 Chapter 3 
the ethanol phase (Ruohonen, Aalto et al. 1995). It is also reported that the final yield of protein is 
greater using this version of the promoter, instead of the middle of long version (Monfort, Finger et al. 
1999). The modifications in this vector implicated the substitution of the original auxotrophic marker 
for a dominant one, TRP1 for KanMX4 respectively, the main enzyme α-amylase, and the secretion 
leader of pheromone α-mating factor (αMF). 
The DNA sequences of the selection marker, the enzyme, and the secretion leader encountered 
themselves in different vectors, and needed to by amplified and purified by PCR and gel extraction 
respectively before cloning in pAMT20. 
 
 
3.1.1. PCR. Sequence-independent cloning  
The traditional cloning strategies involving sequential steps of DNA amplification, digestion, 
ligation, subsequent transformation, purification, and restriction analysis are labour intensive and time 
consuming because only one insert at a time can be cloned on the desired vector. Seamless cloning 
and assembly techniques allow the assembling of more than one insert at a time, and thus were chosen 
to assemble five PCR products into one final vector: Linearized pAMT20, KanMX4, α-Amylase, αMF, 
and terminator (see Figure 3 for illustration). 
The constructs were amplified by PCR using the circular plasmids as templates. Primers used in 
PCR reactions (Table 1) to amplify each construct produce overhangs with overlapping sequences of 
about 18 to 25 base pairs essential for homologous recombinant techniques. Good amplification yields 
were obtained (Figure 2), and each band was gel purified, and stored at -20 ºC until further use.  
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Figure 2 - Agarose gel electrophoresis of PCR products. Individual PCR reactions to amplify each of the DNA inserts. Names 
above Gel lanes correspond the amplified construct, and numbers correspond to 1kb DNA ladder band sizes. Terminator and 
αMF have around 250 bp; Linearized pAMT20 around 4500 bp; αAmylase and KanMX4 cassette have around 1500 bp. 
 
 
 
Figure 3– Schematic illustration of Seamless ligation cloning principle. Figure illustrates how overlapping regions work in the 
final assemble. These overlapping ends are created simply with primer overhangs. 
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3.1.2. Circular Extension polymerase cloning - CPEC 
Circular Polymerase Extension Cloning (CPEC) is a sequence-independent cloning and is largely 
based on homologous recombination. For synthetic biology applications involving high-complexity or 
multi-fragment cloning, sequence-dependent methods are generally inconvenient because they 
require unique and specific sites in both the insert and the vector in order to generate the initial 
plasmids. For this reason, the more flexible sequence-independent cloning methods are preferred. 
However such methods usually require generating complementary single-stranded overhangs in both 
the insert and vector fragments. CPEC relies entirely on the polymerase extension mechanism, and 
overlapping regions between insert and the vector fragments after annealing, work as primers and are 
extended with a polymerase to form a complete circular plasmid and therefore its name (Figure 4). If 
assembling involves multiple Inserts, overlapping regions need to be designed with approximately 
same melting temperatures, between 60 and 70 ºC, and cycling steps need to be augmented (up to 25 
cycles). 
 
Figure 4 - Gene cloning using CPEC. A- Schematic representation the purposed mechanism for cloning individual gene. The 
vector and the insert share overlapping regions at the ends. After denaturation and annealing (step 1), the hybridyzed insert 
and vector extend using each other as template until they complete a full circle and reach their own ends (step 2). The final 
completely assembled vector has two nicks, one on each end, marked by the position of the arrow head. They can be used for 
transformation (step 3). B – Schematic representation of multi-way CPEC. Any of the neighbouring fragments share an 
overlapping region with identical 
 
 
Assembling of all five PCR products in a single reaction was unsuccessful, and after several tries 
no band could be visualized on agarose gel, neither positive clones generated. Since five overlapping 
regions are present, and need to anneal at the same time, if only one fragment fails to anneal, final 
product formation in subsequent cycles will be reduced or inexistent. The first modification realized to 
produce results was to experiment several annealing temperatures, from 55 until 72 ºC, with and 
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without annealing ramps (0.1 ºCs-1), but all produced no positive results. Vector concentration increase 
was also assessed, but the highest concentration used in a single reaction was 150 ng and this could 
be limiting the success rate of whole procedure. Augmenting vector concentration could lead to 
positive results. 
Likewise assembling five pieces together with our constructs could be too demanding, so 
fragment numbers were reduced for each reaction. For example, first introducing PCR amplified 
KanMX4 cassette into the linearized vector (Primers F3_R and F5_F to linearize the vector) generating 
pA20MX4. After in vivo replication and purification, the next step would join PCR products αMF, αAMY 
and pA20MX4 in one CPEC reaction, thus assembling less than 4 DNA fragments at a time. The other 
way around was also used as strategy to circumvent the multi-way CPEC reaction. First αMF, αAMY 
and pAMT20 assembling through CPEC, E. coli replication, purification, and final reaction with pAMT20 
(with both α inserts cloned) and KanMX4 PCR product. Again annealing ramps, variation of cycle 
number (5, 10, 20, and 25), and different polymerases tested produced no other results than negative 
clones.  
The negative clones, when analysed through restriction pointed always to the same issue, which 
was the fact that only the native vector was being internalized into E .coli cells. This native pAMT20 
contamination comes probably from the linearized vector sample which was gel purified, because the 
PCR product and native vector have similar molecular weight in all CEPC assembling. Native vector was 
probably gel purified along with the PCR amplification linear vector justifying its appearance in clones 
transformed with CPEC reactions. The use of DpnI could eliminate this contaminant, and increase the 
frequency of positive clones, but other techniques, such as Gibson, In-fusion and restriction ligation 
cloning, were set forward to circumvent the problem and CPEC left behind. 
 
 
3.1.3. Gibson and In-Fusion 
 
These techniques resemble CPEC, in that they depend as well on overlapping overhangs in DNA 
fragments, but differ in the mechanism used to soe DNA chains together. Gibson Assembly™ and In-
Fusion®HD are isothermal single-reaction methods to assemble multiple DNA fragments, which 
depend on the concerted action of a exonuclease, a DNA polymerase and a ligase (ligase is only present 
in Gibson). It basically starts with the exonuclease which recesses the double stranded DNA fragments 
in the solution, yielding single-stranded DNA overhangs that specifically anneal (due to overlapping 
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sequences), a polymerase which completes the missing strand, and a ligase that covalently joins the 
DNA fragments (In-fusion relies on in-vivo reparation of the nicked strands, thus it does not contain a 
ligase) (Figure 5). The reactions are incubated during 60 and 15 min, for Gibson and In-fusion 
respectively, in a thermocycler and visualized on gel for or transformed directly in competent cells. 
 
 
Figure 5 - GibsonTM One-step isothermal in vitro recombination. Two adjacent DNA fragments sharing terminal sequence 
overlaps (black) were joined into one covalently sealed molecule in a one-step isothermal reaction. T5 exonuclease removed 
nucleotides from the 5’ ends of double stranded DNA molecules, complementary single-stranded DNA overhangs annealed, 
Phusion DNA polymerase filled the gaps and Taq DNA ligase sealed the nicks. Adapted from (Gibson, Young et al. 2009) 
 
Similar to CPEC, five fragment assemble turned out to be complicated and strategies, which 
involved less fragments per reaction, were assessed. In-fusion never produced bands on agarose gel 
or positive clones in any strategy, but with Gibson, when assembling five DNA pieces, a slight band 
near 8000 bp was generated twice (in to consecutive experiments). This would be exactly the product 
we were looking for, so bands were gel purified and used to transform several different competent 
cells. Disappointingly, no transformants generated, not even electrocompetent cells. Reaction was 
repeated one last time, but this time reaction mixture directly to transform competent cells, and only 
negative clones, harbouring the native plasmid, were transformed. Competence of cells might have 
influenced the lack of positive transformants, or again DNA concentrations should be increased even 
further (until 200 ng).  
At this stage, and to drop out of this negative results cycle, digestion-ligation cloning was set at 
full speed to construct the vector the fastest way possible, to recover the time lost, and the seamless 
cloning techniques set aside. 
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3.1.4. Digestion-Ligation cloning 
 
Vector assembly was successfully achieved using traditional cloning techniques. Figure 8 
represents the schematic assembling steps to help understand the full vector assemble. At this stage, 
primers listed in table 2 and Taq polymerase were used to amplify DNA sequences, PCR products were 
gel purified and ligations performed using pGEM-T. After restriction analysis and automated 
sequencing confirmation (Figure 7), Inserts were double digested from pGEM-T easy and gel purified. 
Figure 6 does not discriminate sub-cloning steps in pGEM-T easy, but the inserts sub-cloned in 
this vector were KanMX4 and α-Amylase. KanMX4 was first amplified to generate NdeI/BsrGI 
restriction sites, gel purified, cloned in pGEM-T easy, confirmed by restriction analysis and sequenced. 
After confirmation, KanMX4 inserted in pGEM-T easy was digested, separated on agarose gel and band 
purified. Vector pAMT20 was also amplified to generate same restriction sites through PCR, treated 
with DpnI and purified using PureLink-quick gel extraction kit. KanMX4 DNA insert with cohesive ends 
was ligated to digested vector and again analysed by restriction analysis (Figure 6A) and automated 
sequencing. The same procedure was used to clone α-Amylase in pGEM-T easy. But first amylase was 
engineered by PCR reactions to introduce a His-Tag in the C-terminal, and a second PCR to introduce 
restriction sites (BglII/SalI). The choice of using α-MF from pKLAC1 (K. lactis pheromone secreting 
leader), instead of α-MF from pPICZαA (S. cerevisiae pheromone secreting leader) was the 
compatibility of restriction sites between pAMT20 and pKLAC1. Double digested amylase insert was 
ligated to vector pKLAC1 (previously double digested, treated with CIP, followed by liquid purification) 
and confirmed as described previously (Figure 6B).  
The final step in this strategy was to amplify the α-MF_α-Amylase construct (simultaneously 
producing BamHI/SalI restriction zones) from pKLAC1_AMY (Figure 6 C), through a PCR reaction and to 
clone this sequence into pA20MX4 (pAMT20 already containing KanMX4 cassette), confirmed by 
restriction and automated sequence analysis (Figure 6C, D and 7). After all this laborious process, the 
final vector, named pAα20MX4_AMY was used for transformation procedures using Yeast lab strains, 
to assess if it is working properly, to proceed to liquid protein expression and high throughput 
transformation of the yeast library. 
Figure 7 show the automated sequence analysis of sequences that need to be faithfully inserted, 
namely in-frame cloning of α-Amylase with αMF (Figure 7A), Histidine Tag (essential for later 
purification procedures) and stop codon (Figure 7B), and selection marker KanMX4 cassette (Figure 
7C). 
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Figure 6 - Agarose gel electrophoresis of Restriction analysis for vector assembling. In all examples, left lanes correspond to 
1kb DNA ladder. A – KanMX4/pAMT20 restriction analysis with PstI (467 and 5406 bp); B – α-Amylase/pKLAC1 restriction 
analysis with Msc1 and XhoI (1000 and 9000bp); C – Final assembled vector restriction analysis with ClaI (1113 and 6438 bp); 
D – 2nd Confirmation of final assembled vector restriction analysis with NcoI (2000 and 5567 bp) 
 
 
Figure 7 - Part of sequencing electrophorectogram of the final vector assembled. A – Sequenced zone of αMF/α-amylase 
interface, confirms in-frame cloning of α-amylase with αMF in final vector. B – Sequenced zone harbouring the His-tag and 
stop codon in C-terminal of α-amylase. C – Part of sequencing electrophorectogram of KanMX4 cassette. 
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Figure 8 – Vector assembly with Digestion-ligation cloning. A – KanMX4 insertion in pAMT20. Both molecules are first PCR 
amplified to insert NdeI/BsrGi sites. B – His-tag and restriction sites are introduced in amylase with two consecutive PCR and 
cloned into pKLAC. Insert αMF αAMY is PCR amplified to insert restriction sites BamHI/SalI. C – final Insert is cloned in 
pAMT20. 
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3.2. S. cerevisiae transformation – LiAc/SS-carrier/PEG method 
The introduction of exogenous DNA into yeast by transformation has become an essential 
technique in molecular biology. Transformation is used to investigate the genomics and proteomics of 
yeast itself and also when yeast is employed as a system to study the genes and gene products of other 
organisms (Ideker, Galitski et al. 2001). Intact yeast cells can be transformed by a number of 
procedures: the lithium acetate/single-stranded carrier DNA/polyethylene glycol (LiAc/SS-Carrier 
DNA/PEG) method (Gietz, Schiestl et al. 1995), electroporation (Becker and Guarente 1991), agitation 
with glass beads (Costanzo and Fox 1988), and bombardment with DNA-coated microprojectiles 
(Johnston and DeVit 1996). The most widely used and with easy and practical application in the high 
throughput transformation is the LiAc PEG (Gietz and Schiestl 2007). 
The first attempt to transform yeast with the pAα20MX4_Amy was accomplished with the lab 
strains, W303 and CEN.PK2 using a medium scale transformation protocol.  
 
Figure 9 - Lab strains plated on YPD + 2% starch and stained with lugol solution. On the left side are the transformed lab 
strains, with clear hallo formation around colonies. Negative control on the right side. Native strains do not form halos. The 
white area visible in the W303 are not degradation of starch. More lugol was added afterwards and those areas stained as 
well (Data not shown). When stained, the plate was shaken vigorously and colonies were displaced. Adding more lugol stained 
that area (Data not shown) 
 
This assay shows that α-Amylase is secreted in an active form, thus the vector is working as well 
as the activity assay. The white area on the negative controls are not starch degradation. More lugol 
was added later, and those area turned black. If starch degradation had occurred (for example, the 
strain secretes and endogenous amylase) then the agar + starch medium would not stain, no matter 
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how much lugol added. The problem results from vigorous plate shaking to distribute lugol all over the 
area.  
Proving that the vector was working allows us to move to protein expression in liquid medium using 
lab strains. The purpose is to establish a threshold for protein level production in a lab strain, and later 
compare these levels produced by a selected candidate from the Yeast library. Before moving into 
large-scale, a small scale expression was performed to assess the time of expression to yield sufficient 
amount of protein. 
 
 
3.3. Small scale protein expression in lab strains 
Time course for protein expression performed with CEN.PK2 and W303 lab strains was started 
at the same time by pré-inoculum in a small volume medium. Next day, culture medium was diluted 
until 0.2, and samples collections started when O.D reached 0.8. Due to imparity in growth rates 
between lab strains, W303 (which grows at slower rates) time course was delayed 12 hours. 
Samples were collected for 72 h (60h in W303), immediately denatured using 6x loading buffer 
and stored at room temperature. Salivary α-Amylase has 57kDA and is reported in yeasts to be 
glycosylated in yeast, so two bands could appear in SDS-PAGE and western blot. Figure 10 shows the 
time course of both lab strains, and some protein in present in the supernatant, but these proteins are 
probably endogenous secreted proteins or from cell lysis during growth, because Western-blot analysis 
is clear. Protein at this stage is too diluted, and therefore is not detectable even with a Western-blot 
analysis. 
Next thing to assess was to verify the intracellular content of the collected samples. In theory, 
most of the amylase produced should be secreted, but apparently this was not the case, and more 
signal is detected from intracellular fractions than the supernatant (Figure11). We conclude that α-
Amylase is being retained inside the cells. Thomsen (1983), used ADH1 promoter and α-amylase native 
signal peptide to secrete Mus musculus α-Amylase produced in S.cerevisiae. They reported with this 
signal peptide over 90% exportation of amylase to the extracellular medium and practically no protein 
accumulated inside cells. Using only the signal peptide of K. lactis could increase secretion levels, but 
reported literature says otherwise, and excluding some exceptions, α-prepro region is needed to 
efficiently secrete proteins in S. cerevisiae (Li, Xu et al. 2002).  
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Figure 10 - Protein expression timecourse in lab strains analysis. Only supernatant of culture medium is analysed. 250 µl 
samples were denatured with 6x loading buffer and 50 µl applied to each lane either for SDS-PAGE followed by Coomassie 
staining of for western blot analysis. In both cases 12.5% acrylamide gels were used. The number above lanes correspond to 
times of sample collection. M – molecular weight marker; T0 – OD600 0.8; T1 – 12h; T2 – 24h; T3 – 36h; T4 – 48h; T5 – 60h; T6 
– 72h. a) SDS PAGE followed with Coomassie staining. b) Western blot analysis with anti-His tag antibody of the same SDS-
PAGE samples of CEN.PK2. c) and d) correspond to SDS-PAGE and Western-blot from W303 respectively. 
Figure 11 -Western blot analysis of intracellular protein content. Screening of intracellular samples of both lab strains, 
CEN.PK2 and W303 for recombinant α-Amylase. Samples were denatured with 6x loading buffer and 50 µl applied to each 
lane for western blot analysis. 12.5% acrylamide gels were used. The letters above lanes correspond to the strain (C for 
CEN.PK2, and W for W303) and numbers correspond to times of sample collection. M – Molecular weight marker T3 – 36h; T4 
– 48h; T5 – 60h; T6 – 72h 
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Figure 12 - Alfa mating factor secretion leader sequence in yeasts. Sequence of both yeast prepro-αfactor. Underlined are 
the signal peptides cleaved early in the secretory pathway. Light grey boxes represent N-glycosylation, and asparagine is 
evidenced in bolt. 
 
The secretion leader of S. cerevisiae is composed of 89 a.a., that consists of 19 a.a signal peptide 
and 64 a.a pro-region containing 3 glycosylation sites The nascent polypeptide is translocated into the 
endoplasmic reticulum (ER), where the signal sequence is cleaved to produce pro-α-factor (Waters, 
Evans et al. 1988), and core N-linked carbohydrate is added to the three sites within the pro region. K-
lactis leader only possesses 2 glycosylation sites instead of the tree from S. cerevisiae (Figure 12). 
Prepro region of αMF in saccharomyces and K. lactis only share 48% of similarity, which is quite low. 
Caplan et al. studied the effect of alterations in glycosylation and sequence of pro region from 
αMF. Their results showed that deleting one two or all three glycosylation sites in the pro-region lead 
to increasing reduction of alpha factor secretion respectively (with concomitant intracellular 
accumulation). But some alpha factor could still be secreted. Also, when they altered the pro region 
sequence (either with insertions or deletions) the same effect as eliminating glycosylation sites 
occurred (Caplan, Green et al. 1991). Adding this to our information, both glycosylation’s and pro 
region sequence of prepro-αfactor differ in S. cerevisiae and K. lactis. Together this differences are 
probably responsible for delaying α-amylase secretion, resulting in intracellular accumulation. Due to 
time constrains, exchanging the secretion signals in pAα20MX4_Amy was not possible and we had to 
continue. 
As Caplan et al. reported, some Alfa mating factor is still being secreted and thus we decided to 
proceed to large scale protein expression even with the inconvenience of an adequate leader. Looking 
at figure 15, CEN.PK2 produces more protein than W303, when comparing for instance, the protein 
levels at 60h, a band near 60 kDa is visible in CEN.PK2 but not in the W303 lane. The western-blot 
(Figure 11) shows another band at 75 kDa, which might be a hyperglycosylated form of α-amylase. 
Despite the increase of 25 % in apparent molecular weight, there are cases reported with an increase 
in molecular weight of 30 % in hyperglycosylated proteins by S. cerevisiae, corresponding to 120 
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residues of mannose. (Bulter, Alcalde et al. 2003). This supposed hyperglycosylated form is also visible 
in W303 timecourse.  
 
 
3.4. Large scale protein expression and purification 
 
Despite the poor secretion of amylase from recombinant yeasts with our plasmid, we still 
proceeded to a large scale protein expression. This large scale assay was to establish a threshold with 
the lab strains, to later compare performances of the candidate strains discovered from the library. 
We started the scale-up with the CEN.PK2 strain. After 120 hours of growth, cell culture was 
centrifuged and concentrated over several steps, as described in materials and methods. Samples were 
collected of every step to later evaluate the protein content. Despite the scale-up, recombinant protein 
levels are barely detected on SDS-PAGE (figure 13). A band near 60 kDa, indicated by the black arrow, 
could correspond to α-amylase. The western blot shows that α-amylase is mostly accumulated inside 
the cell, and barely detectable in the supernatant of culture medium. After tangential filtration 
concentration, some protein signal is detected, but then is lost after concentration by precipitation 
with 90 ammonium sulphate. The LDP stands for “Low Density Precipitate”, and appeared on the 
surface, when high concentrations of salt was being added to precipitate protein. After 2 hours in high 
salt concentration, medium was filtered with glass wool, to remove the LDP and procedures carried 
on. The LDP was resuspended and stored at -20ºC until further use. It would later be discovered that 
most amylase is being retained in this LDP decreasing protein levels in subsequent purification steps, 
and no visible protein in lanes PrBF and PrAF. 
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Figure 13 - α-amylase purification analysis through SDS-PAGE and Western blot. The samples were denatured with 6x 
loading buffer at 95ºC for 10 min and 50 µl were loaded in the wells (except for IC in SDS-PAGE where only 5 µl were loaded). 
SDS-PAGE and western were made in 12.5% acrylamide gels. M – molecular weight marker; IC – Intracellular fraction; EC – 
extracellular fraction; TC – after tangential filtration; LDP – Low Density Precipitate, appeared during precipitation with high 
salt concentration; PrBF – after Precipitation with 90% ammonium sulphate, Before Filtration; PrAF – after Precipitation with 
90% ammonium sulphate, After Filtration. a) Analysis by SDS-PAGE. b) Western blot analysis with anti His tag antibody 
 
 
 
Figure 14 - Amylase activity assay. Agar plates with all the samples from the purification steps Solid medium is composed of 
50mM Hepes Buffer, 5mM CaCl2 pH 6.9, 2% starch and agar (20g/L). IC – Intracellular fraction; EC – extracellular fraction; TC 
– after tangential filtration; LDP – Low Density Precipitate, appeared during precipitation with high salt concentration; PrBF 
– after Precipitation with 90% ammonium sulphate, Before Filtration; PrAF – after Precipitation with 90% ammonium 
sulphate, After Filtration; 3- 20mM phosphate pH 7.5 buffer with 100mM NaCl. 
 
From figure 14 we can easily see the difference between intracellular fraction (IC) and supernatant 
(EC), but the increase in activity after concentration with tangential filtration (TF) indicated that some 
amount of protein is still being secreted, and purification carried on. As discussed before, a low density 
precipitate (LDP) formed in the high salt concentrated solution, and contained higher activity levels 
66 Chapter 3 
compared with the other precipitate (PrAF). Avoiding LDP formation could simply be performed by 
filtration, through 0.2 µM membrane, of TF sample before high amounts of salt is added. Looking ate 
the results, and because protein purification present in the supernatant was our main objective, LDP 
was prepared to be injected in size exclusion column Superdex 200 26/60 prep grade. 
LDP sample was sequentially filtered through 0.8µ, 0.45µ, and 0.2µ membranes, 9 mL were applied 
to size exclusion column, previously equilibrated with 20mM phosphate pH 7.5 buffer with 100mM 
NaCl and 10 ml fractions were collected and analysed by SDS-PAGE and western blot. The 
chromatografic profile is shown in Figure 15.  
The medium composition has a charecteristic brown pigment, and as purification steps advance, 
the intensity of the brown solution incresaes. This pigment then is separated in the superdex 200 26/60 
prep grade to separate amylase from the pigment (starts to exit column after 230 ml in chromatogram). 
This pigment saturates the UV detector, thus only initial chromatogram profile is shown here. The 
fractions colected are represented above the peaks and were analysed in agar plates for activity, and 
in SDS-Page/Western blot. 
 
 
Figure 15 - Purification of LPD α-Amylase in size exclusion chromatography. Superdex 200 26/60 prep grade column 
equilibrated in 20mM phosphate pH 7.5 buffer with 100mM NaCl and 10 mL samples were collected. The elution occurred at 
a flow rate of 2 mL/min (at room temp) and A280nm was used to monitor protein elution. Outlined by dotted lines in the 
chromatogram are elution volume of collected fractions analysed by SDS-PAGE and Western blot. Note that Sample volume 
comprises the 5ml before and after dotted line. 
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From previous handling with the column in the lab, amylase should be eluted around 150 mL, but 
the correspondent peaks, have low amount of protein according to Absorbance units. The activity of 
LDP is not lost through the filtering process (Figure 16), but after passing through the size exclusion 
column, is completely lost or residual. Fractions 19 and 20 have some residual activity but is considered 
insignificant compared to levels seen before separation by chromatography. Western blot also shows 
signal for histidine tag fused in α-amylase C-terminal, in filtered samples, but no signal is seen in 
fractions collected from Superdex column. This western procedure was performed using. 
This low density precipitate of unknown source and amylase embodied in it is active in solid 
medium assays, but disappears when injected in the column. Amylase could be forming protein 
aggregates, but this would be seen with a bigger peak in the chromatogram, as protein aggregates 
normally are eluted after 100 ml (corresponds to void volume). 
 
 
 
 
Figure 16 - LDP Amylase activity assay. Solid medium composition 50mM Hepes Buffer, 5mM CaCl2 pH 6.9, 2% starch. 0.8µM, 
0.45µM and 0.2µM – represent the SFM sample filtered through membranes with respective pores sizes. Right image – zoom-
in to visualize activity in samples separated in size exclusion chromatography. 20 µl were loaded in each well. 
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Figure 17 - LDP α-amylase purification analysis through SDS-PAGE and Western blot. The samples were denatured with 6x 
loading buffer at 95ºC for 10 min and 50 µl were loaded in the wells. SDS-PAGE and western were made in 12.5% acrylamide 
gels. M – molecular weight marker; 0.8 – LDP filtered with 0.8 µM membrane; 0.45 – LDP filtered with 0.45 µM membrane; 
0.2 – LDP filtered with 0.2 µM membrane. Fn – fractions collected from Superdex 200 26/60 prep grade. 50µl were loaded in 
each well a) Analysis by SDS-PAGE. b) Western blot analysis with anti His tag antibody 
 
Since amylase purification from LDP failed, we started procedures to purify amylase remaining 
in the other precipitate, correspondent to PrAF sample in figure 14. The PrAF samples was already 
filtered and 9ml were applied to a size exclusion chromatography Superdex 200 prep grade, previously 
equilibrated in 20mM phosphate pH 7.5 buffer with 100mM NaCl, and 10 mL fractions were colected 
and analyses by SDS-PAGE and western blot. Fractions colected are shown above the peaks and were 
analysed in agar plates for activity and in SDS-Page/Western 
Peaks of this sample chromatogram (Figure 18 a) look more homogeneous, and have bigger 
absorbance units, but the activity remained residual (Figure 18 b), and not detectable by SDS-PAGE or 
western blot (Figure 18 c, d). The samples with residual activity in this chromatography were eluted in 
a different volume from first chromatogram (150 instead of 200ml). A different Superdex 200 26/60 
prep grade was used this time and could be the reason for this difference. LDP sample had a higher 
viscosity and could retard amylase elution. Both way, activity remained reduced and this let could be 
due to a series of reasons.  
The first reason could rely on amylase nature, and the matrix from the size exclusion column. 
Amylase (EC 3.2.1.1) hydrolyses α-1, 4-glucosidic bonds in polysaccharides, (such as starch), and could 
interact with column resin. Superdex, a registered trademark of GE Healthcare resin, is made of cross-
linked dextran with highly cross-linked agarose. Dextran is a polymer of glucose units consisting of α-
1, 6 glycosidic linkages between glucose molecules and α-1, 3 linkages braches and agarose is a linear 
polymer of D-galactose and 3, 6-anhydro-1-galactose. Amylase might interact with the column matrix 
and be eluted much later than expected. 
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Figure 18 - Purification and analysis of precipitated protein in High salt concentrations (PrAF sample). a) Superdex 200 26/60 
prep grade column equilibrated in 20mM phosphate pH 7.5 buffer with 100mM NaCl and 10 mL samples were collected. The 
elution occurred at a flow rate of 2 mL/min (at room temp) and A280nm was used to monitor protein elution. Outlined by 
dotted lines in the chromatogram are elution volume of collected fractions analysed by: b) activity assay in solid medium 
(50mM Hepes Buffer, 5mM CaCl2 pH 6.9, 2% starch) and 20ul were loaded in each well; c) SDS-PAGE and d) Western blot. 50 
ul were loaded in each well 
 
Samples were only collected until 230 ml and did not have any activity on solid medium (Data 
not shown). Literature does not provide an equal example to compare, there have been reports of 
glucosidades with same α-1, 4 linkage specificity, purified with Superdex matrix without complications, 
although no size exclusion chromatography was used for their purpose (Van Hove, Yang et al. 1997). 
Another, more appealing causes for protein loss in the column would be aggregation and retention 
in the columns pre-filters. The buffer to resuspend, either the pellet of desalted protein (last 
chromatogram) or the LDP, is the same as the buffer used to equilibrate the column. So the protein 
does not suffer an abrupt environment change, caused by buffer switch. Maybe Amylase is unstable in 
this buffer and aggregates when resuspended, or aggregation is due to the previous treatment with 
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high salt concentration. As said before, amylase depends on Ca2+ to be active, and this particular detail 
could be influencing our experiments.  
Stein et al, say that modifications of the secondary or tertiary structure in amylases might result in 
easy release of calcium ions, a conditions too such modifications could be, variation in pH, use of 
organic solvent or high salt concentration (Herberhold, Royer et al. 2004) Stein et, al. using EDTA as 
chelating agent, proved that denaturation induced by calcium release from active site of amylases was 
reversible simply by adding more calcium to the medium (Stein and Fischer 1958). High salt 
concentrations were used in our protein purification protocol, which could drive amylase to 
conformation and aggregate in chromatography columns. But amylase samples with high salt content 
also demonstrates activity in the agar plates. Agar plates contain calcium in their composition, and 
when amylase diffuses into the solid medium, conformation is restored and amylase active again.  
In literature, reported cases of Mus musculos salivary α-Amylase expression and purification from 
yeasts included calcium in their buffers for chromatography (Thomsen 1983, Kato, Ishibashi et al. 
2001). Thus adding calcium to resuspension buffer could recover all the protein loss, allowing for 
further activity assays and to set a threshold for comparison with a potential candidate from the Yeast 
wine library. 
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3.5. 96 microtiter well transformation protocol - Optimization 
 
The transformation protocol needed to be validated before proceeding to high throughput, so 
a reduced number of yeast strains was used in this initial stage. In the first assay, 106 – 107 cells per 
well were used, 600 ng of plasmid DNA, and incubation at 42ºC during one hour were tested. The cell 
concentration was maintained through all procedures, plasmid DNA concentration and heat shock 
times were varied until transformation protocol was successful.  
The first transformation in 96 microtiter multiwell, using lab strains W303, CEN.PK, and two 
random S. cerevisiae strains from the library resulted only in lab strains transformation (Figure 19 c). 
Controls were performed as normal transformation procedures, but with no plasmid DNA, all the other 
reagents were added. 
In subsequent trials, and with more wine yeast strains the results were always the same. Lab 
strains were transfromed but not the wine strains. Wine yeasts are different from lab yeasts. In their 
natural environment they are exposed to severe conditions, particularly in fermenter tanks. So their 
exterior wall must somehow be more rigid, and thus less permissive for plasmid incorporation 
The original protocol suggests a set of conditions to be tested with different concentrations or 
incubation times. Due to time constrains the plasmid DNA concentration was raised to 1.7 µg per well, 
incubation time at 42 ºC was performed during 3h, and only strains from the library were used. 
From 16 random S. strains selected from the library, almost all of the yeasts were transformed 
and formed halos around the colonies (Figure 20). The transformation rate with this conditions was 
above 90 %, so the protocol was optimized and high throughput procedures were carried on 
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Figure 19 - Positive clones from the first round of 96 microtiter multiwell transformation protocol. A – Positive clones plated 
on selective medium containing 200 µg/ml G418. B – Controls of plated yeasts transformed without plasmid DNA. C – Amylase 
activity confirmation of positive clones plated on selective medium containing 200 µg/ml G418 and 2% starch and stained 
with lugol solution. 
 
 
Figure 20 - Positive clones transformed with the final protocol modifications. 16 random strains from the library were 
transformed and plated on YPD medium supplemented with 200 µg/ml G418 and 2% starch. Plates were stained with lugol 
solution 
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3.6. High throughput Screening – Controls 
 
Approximately 400 S.cerevisiae strains from the library were transformed as described in materials 
and methods. Two controls were designed for this purpose. One with antibiotic (agar plates 
supplemented with 200 µg/mL G418), to assess whether yeast strains were naturally resistant to G418 
antibiotic. And another control on YPD agar plates supplemented with 2% starch (without antibiotic), 
to discriminate the strains capable of secreting their own amylases or other enzymes capable of 
degrading starch.  
In total, 6 deepwell plates were used for the screening. Each well contains 80 strains of S.cerevisiae 
(16 wells serve as control). Figure 21 is only a representative example of the controls. In total, none of 
the 400 native strains were capable of forming halos, and only 1-3 % of the strains had natural 
resistance to 200 µg/mL G418. Several antibiotic concentrations were tested to eliminate this natural 
resistance, and 200 µg/mL was found to be the best concentration to minimize natural capability of 
yeasts strains to grow in selective conditions. Concentrations at 60 µg/mL were insufficient, as resistant 
yeasts strains increased to 11 %, and 300 µg G418 was no better than the 200 concentration. 
In the starch control, none of all strains formed halos, so all halo formation in transformed yeast 
are assured to result from our plasmid DNA. 
This screening was performed in a high throughput Sciclone ALH 3000 Workstation which 
transfered cells from deep well plates, to single wells plates with the specifc solid medium, and plates 
were grown O.N.. 
 
Figure 21 - High throughput Controls of S. cerevisiae library. Strains were picked from the deep well plate with the help of 
the Sciclone ALH 3000 Workstation-Caliper robot and the 96 pin tool, and plated on solid YPD. Left – single well plate with 
solid YPD + 200 µg/mL G418. Right – single well plate with solid YPD supplemented with 2% starch stained with lugol solution. 
Wells H(3,6,9,12) don’t have cells and serve as controls. E (3,6,9,12) are comercial wine yeast Lalvin EC118; F (3,6,9,12) have 
comercial wine yeast QA23; G (3,6,9,12) have the lab strain s228.; 
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3.7. High throughput transformation 
As explained above, after transformation protocol optimization, high throughput 
transformation was carried on. A total of 392 yeast strains, organized in 6 deep well plates were 
successfully transformed and halos around colonies formed. These strains would be isolated and 
further characterized to validate them as powerful recombinant protein expression system to use in 
the lab. Other laboratories with their own yeast libraries, upon screening, obtained 3 or 4 suitable 
candidates from the library suitable for heterologous protein expression, and this was our threshold 
as well. Figure 22 shows the transformation of one 96 deep well plate results after strains are grown 
in solid selective medium with starch after staining 
To discriminate between yeasts with high, medium or low levels of protein secretion during 
halo formation, we measured the ratio of halo/colony size of all individuals. The transformed strains 
in this project represent only a small fraction of the whole library, but a significant number of strains 
was transformed and yielded good results. Overall, 82 % transformation efficiencies prevailed using 
this protocol, which can in the future be employed to screen the whole library. 
 
 
Figure 22 - High throughput activity assay. Example of a single well plate with transformed colonies plated on YPD solid 
medium supplemented with 200 µg/ml G418 and 2% starch. The image fragment contains lab strains transformed and grown 
in the same conditions. R stands for random yeast strain belonging to the library 
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Figure 23 Activity…. X axis represents the interval of values, ploted against the number of colonies with rations between this 
gab. There are 82 strains with ratios between 1 and 1.0999, 83 strains with ratios between 1.1 and 1.1999 etc. Bars represent 
number of colonies, and black line represents the same data in percentage.  
 
 
Figure 23 holds the graphic in with ratios were plotted against number of colonies. Basically it 
represents the number of strains with in a given interval of ratios. So colonies with ratios between 1 
and 1.099 were 82 exemplars and so on. Most of the exemplars screened have small or medium values 
for ratios, and the number of candidates decreases for bigger ratios. From these analysis, we can see 
that there are some exemplars with ratios near 2. That represents a halo with double size of the colony. 
These strains are strong candidates to proceed to further characterization and establishment of an 
expression system. Overall, form about 392 strains, 3 good strains chowed higher protein capacity 
evidence. 
If more candidates are screened, some more and maybe better strains will arise. Biodiversity 
of such libraries have proven invaluable and can outweigh genetic engineering performed in strains, 
and increase the understanding of the mechanisms behind the new features discovered. These strains 
have evolved over millions of years and can have some enhanced genetic traits for use in the 
laboratory, or even in industry. The reports about other yeasts (P. pastoris) outrunning S. cerevisiae in 
recombinant protein production is, in most times compared to lab strains and not, for instance, to 
industry strains used for protein production. These industry strains are highly protected and only rare 
reports are found in literature. They can probably perform 10 x (or more) the production of the best 
lab strains known of saccharomyces cerevisiae. 
Some improvements can still be made to fine tune this screening. The possible problem with 
the secretion leader can be hiding the true potential of some strains in producing and secreting 
76 Chapter 3 
recombinant protein. Another issue not mentioned until now in our screen is the percentage of agar 
used in solid medium plates. Agar plates are constituted of polymers with form an intrinsic net of pores 
with variable sizes which can influence the diffusion of macromolecules such as proteins. The bigger 
the percentage of agar used, the more restrictive becomes the intra space of the gel, and adding to 
this, 2 % starch are added to mixture in our experiments and makes the 3D structure of the gel even 
more rigid. These factors can influence Alfa amylase diffusion through the gel, and even if starch is 
degraded in the process, less concentration of both could lead to bigger halo formation. 
Not much is available about the influence of protein size and diffusion of proteins in agar. 
(Ackers and Steere 1962) tested the restriction diffusion coefficient of several proteins through agar 
membranes ranging from 1-8 % concentration. They used commercial Haemoglobin (67 kDa), γ-
globulin (160 kDa), serum albumin (69kDa) and Ribonucleases (13 kDa) and saw clear differences in 
restriction diffusion measurements according to the size of the protein, and more important, they also 
saw how agar gel % influences. In their case, agar membranes were used which is different from agar 
plates, but still it indicates that the pores sizes on agar significantly affects diffusion of macromolecules 
such as proteins. A simple test in laboratory can be made to assess whether α-amylase is influenced in 
our experiments, and if it is significant or not. This could lead to better and more accurate 
measurements of the halos helping to differentiate a good strain form an excellent one in our context.  
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4.1. Conclusions and future remarks. 
The major goal of the developed work was find stains of S. cerevisiae with enhanced proteins 
production capacity. First, a high throughput protocol for yeast transformation, to screen a S. 
cerevisiae library for potential protein expression systems needed to be assembled. 
The first task consisted in the assembling of an expression vector essential for the later screening 
procedure. In order to overcome Ligation-digestion cloning extensive time a labour drawbacks, CPEC 
Gibson and In-fusion were used to assemble the vector in a short period of time, with less labour 
required and to set-up the seamless ligation techniques in the laboratory. But no positive results came 
from using this techniques and the problem in vector assembling was resolved with digestion-ligation 
cloning. 
With not much information in literature to compare, the prepro sequence of the mating factor 
leader from K. Lactis tested in a S. cerevisiae host seems to be responsible for intracellular 
accumulation of recombinant α-amylase. In literature when glycosylation or sequence of the prepro 
peptide of αMF are altered, intracellular accumulation of protein occurs, which seems to be the case, 
due to low levels of protein yielded in our large-scale experiments. Changing K. lactis for S. cerevisiae 
mating factor secretion leader can yield higher protein levels, and allowing to establish a threshold for 
protein levels using lab strains, and later to evaluate the protein production limits of the relevant 
candidates form the yeast library. 
 Another issue which happened during our experiments was the lack of activity in protein samples 
after purified in size exclusion chromatography. The high salt conditions could be responsible for 
removing Ca2+ from the α-Amylase globular structure leading to inactivation and aggregation, which 
could result in aggregates and are trapped in the column pre-filters. Protein samples in high salt 
concentrations that were not injected in the column do present activity, but this could be related to 
the another feature of α-amylase, which is their ability to regain back its activity in calcium rich 
environments, which in our case correspond to the agar plates with buffer and calcium. Another 
hypothesis is the fact that as a glycosidase, it could somehow interact with the column matrix, 
composed of highly cross linked dextran, which itself is a polymer of glucoses and be eluted in later, 
corresponding to fractions not even collected. Amylase has preference for α-1.4 glycosidic bonds, and 
dextran is made of α-1.6 for linear and α-1.3 for branched bonds nevertheless amylase might still 
interact with this sugars. Other groups have purified glucoamylases in Superdex resins with no 
problems.. 
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Finally, the protocol establishment went successful and high throughput transformations 
performed with efficiency. Some candidates showed up with promising performances from the yeast 
strain library and can be further characterized. Yet some conditions can still be improved to fine tune 
this process. Along with the secretion leader change, the agar concentration in solid medium can also 
be varied to improve the ratios halo/colony to help differentiate good strains from outstanding ones. 
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